Document And Entity Information
Document And Entity Information - shares | 9 Months Ended | |
Sep. 30, 2019 | Nov. 08, 2019 | |
Cover [Abstract] | ||
Document Type | 10-Q | |
Amendment Flag | false | |
Document Period End Date | Sep. 30, 2019 | |
Document Fiscal Year Focus | 2019 | |
Document Fiscal Period Focus | Q3 | |
Trading Symbol | OPBK | |
Entity Registrant Name | OP Bancorp | |
Entity Central Index Key | 0001722010 | |
Current Fiscal Year End Date | --12-31 | |
Entity Filer Category | Non-accelerated Filer | |
Entity Small Business | true | |
Entity Emerging Growth Company | true | |
Entity Ex Transition Period | true | |
Entity Common Stock, Shares Outstanding | 15,702,743 | |
Entity Current Reporting Status | Yes | |
Entity Shell Company | false | |
Entity File Number | 001-38437 | |
Entity Tax Identification Number | 81-3114676 | |
Entity Address, Address Line One | 1000 Wilshire Blvd. | |
Entity Address, Address Line Two | Suite 500 | |
Entity Address, City or Town | Los Angeles | |
Entity Address, State or Province | CA | |
Entity Address, Postal Zip Code | 90017 | |
City Area Code | 213 | |
Local Phone Number | 892-9999 | |
Document Quarterly Report | true | |
Document Transition Report | false | |
Entity Incorporation, State or Country Code | CA | |
Title of 12(b) Security | Common Stock, no par value | |
Security Exchange Name | NASDAQ | |
Entity Interactive Data Current | Yes |
CONSOLIDATED BALANCE SHEETS (un
CONSOLIDATED BALANCE SHEETS (unaudited) - USD ($) $ in Thousands | Sep. 30, 2019 | Dec. 31, 2018 | |
ASSETS | |||
Cash and cash equivalents | $ 89,107 | $ 77,726 | |
Securities available for sale, at fair value | 52,295 | 55,336 | |
Other investments | 9,173 | 7,260 | |
Loans held for sale | 368 | 752 | |
Loans receivable, net of allowance of $9,640 at September 30, 2019 and $9,636 at December 31, 2018 | 954,730 | 865,423 | |
Premises and equipment, net | 5,367 | 4,633 | |
Accrued interest receivable | 3,140 | 3,068 | |
Servicing assets | 6,959 | 6,987 | |
Company owned life insurance (COLI) | 10,551 | 11,394 | |
Deferred tax assets | 2,358 | 3,672 | |
Other real estate owned (OREO) | 1,817 | ||
Operating right-of-use assets | [1] | 8,606 | |
Other assets | 7,463 | 7,935 | |
Total assets | 1,151,934 | 1,044,186 | |
Deposits: | |||
Noninterest bearing | 296,831 | 285,132 | |
Interest bearing: | |||
Savings | 3,316 | 3,421 | |
Money market and others | 274,698 | 261,349 | |
Time deposits greater than $250,000 | 219,547 | 164,281 | |
Other time deposits | 201,601 | 190,993 | |
Total deposits | 995,993 | 905,176 | |
Accrued interest payable | 2,541 | 1,715 | |
Operating lease liabilities | [1] | 10,335 | |
Other liabilities | 5,472 | 7,508 | |
Total liabilities | 1,014,341 | 914,399 | |
Shareholders’ equity | |||
Preferred stock – no par value; 10,000,000 shares authorized; no shares issued or outstanding at September 30, 2019 and December 31, 2018 | |||
Common stock – no par value; 50,000,000 shares authorized; 15,711,580 and 15,860,306 shares issued and outstanding at September 30, 2019 and December 31, 2018, respectively | 87,085 | 91,209 | |
Additional paid-in capital | 7,154 | 6,249 | |
Retained earnings | 43,086 | 32,877 | |
Accumulated other comprehensive loss | 268 | (548) | |
Total shareholders’ equity | 137,593 | 129,787 | |
Total liabilities and shareholders' equity | $ 1,151,934 | $ 1,044,186 | |
[1] | The adoption of ASU 2016-02, Leases (Topic 842) in the first quarter of 2019 resulted in the recognition of right-of-use assets and lease liabilities on balance sheet. |
CONSOLIDATED BALANCE SHEETS (Pa
CONSOLIDATED BALANCE SHEETS (Parenthetical) (Unaudited) - USD ($) $ in Thousands | Sep. 30, 2019 | Dec. 31, 2018 |
Statement Of Financial Position [Abstract] | ||
Loans receivable, allowance | $ 9,640 | $ 9,636 |
Cash, FDIC insured amount | $ 250,000 | $ 250,000 |
Preferred stock, par value | ||
Preferred stock, shares authorized | 10,000,000 | 10,000,000 |
Preferred stock, shares issued | 0 | 0 |
Preferred stock, shares outstanding | 0 | 0 |
Common stock, par value | ||
Common stock, shares authorized | 50,000,000 | 50,000,000 |
Common stock, shares, issued | 15,711,580 | 15,860,306 |
Common stock, shares, outstanding | 15,711,580 | 15,860,306 |
CONSOLIDATED STATEMENTS OF INCO
CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME (unaudited) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2019 | Sep. 30, 2018 | Sep. 30, 2019 | Sep. 30, 2018 | |
Interest income | ||||
Interest and fees on loans | $ 14,278 | $ 12,524 | $ 41,725 | $ 35,042 |
Interest on investment securities | 332 | 249 | 1,019 | 645 |
Other interest income | 502 | 233 | 1,333 | 561 |
Total interest income | 15,112 | 13,006 | 44,077 | 36,248 |
Interest expense | ||||
Interest on deposits | 3,893 | 2,477 | 10,883 | 6,071 |
Interest on borrowed funds | 44 | 146 | ||
Total interest expense | 3,893 | 2,521 | 10,883 | 6,217 |
Net interest income | 11,219 | 10,485 | 33,194 | 30,031 |
Provision for loan losses | 290 | 439 | 691 | 1,047 |
Net interest income after provision for loan losses | 10,929 | 10,046 | 32,503 | 28,984 |
Noninterest income | ||||
Service charges on deposits | 469 | 484 | 1,495 | 1,419 |
Loan servicing fees, net of amortization | 243 | 310 | 853 | 1,006 |
Gain on sale of loans | 1,714 | 1,135 | 4,379 | 3,852 |
Other income | 306 | 355 | 2,185 | 1,002 |
Total noninterest income | 2,732 | 2,284 | 8,912 | 7,279 |
Noninterest expense | ||||
Salaries and employee benefits | 5,349 | 4,803 | 15,862 | 13,629 |
Occupancy and equipment | 1,232 | 976 | 3,441 | 3,065 |
Data processing and communication | 385 | 320 | 1,110 | 948 |
Professional fees | 261 | 294 | 711 | 612 |
FDIC insurance and regulatory assessments | (21) | 106 | 188 | 306 |
Promotion and advertising | 182 | 222 | 543 | 598 |
Directors’ fees | 228 | 216 | 680 | 633 |
Foundation donation and other contributions | 402 | 369 | 1,169 | 1,084 |
Other expenses | 406 | 399 | 1,151 | 1,118 |
Total noninterest expense | 8,424 | 7,705 | 24,855 | 21,993 |
Income before income taxes | 5,237 | 4,625 | 16,560 | 14,270 |
Income tax expense | 1,237 | 1,144 | 3,984 | 3,781 |
Net income | $ 4,000 | $ 3,481 | $ 12,576 | $ 10,489 |
Earnings per share - Basic | $ 0.25 | $ 0.22 | $ 0.78 | $ 0.68 |
Earnings per share - Diluted | $ 0.24 | $ 0.21 | $ 0.77 | $ 0.66 |
Other comprehensive income (loss): | ||||
Change in unrealized income (loss) on securities available for sale | $ 119 | $ (257) | $ 1,158 | $ (863) |
Tax effect | (35) | 76 | (342) | 180 |
Total other comprehensive income (loss) | 84 | (181) | 816 | (683) |
Comprehensive income | $ 4,084 | $ 3,300 | $ 13,392 | $ 9,806 |
CONSOLIDATED STATEMENTS OF CHAN
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (unaudited) - USD ($) $ in Thousands | Total | Common Stock | Additional Paid-in Capital | Retained Earnings | Accumulated Other Comprehensive Income (Loss) |
Beginning balance at Dec. 31, 2017 | $ 91,480 | $ 67,926 | $ 5,280 | $ 18,624 | $ (350) |
Beginning balance, shares at Dec. 31, 2017 | 13,190,527 | ||||
Net income | 3,216 | 3,216 | |||
Stock issued under stock offering, net of expenses | 22,637 | $ 22,637 | |||
Stock issued under stock offering, net of expenses, shares | 2,300,000 | ||||
Stock issued under stock-based compensation plans | 114 | $ 114 | |||
Stock issued under stock-based compensation plans, shares | 40,000 | ||||
Stock-based compensation | 246 | 246 | |||
Change in unrealized loss on securities available for sale net of reclassifications and tax effects | (433) | (433) | |||
Ending balance at Mar. 31, 2018 | 117,260 | $ 90,677 | 5,526 | 21,840 | (783) |
Ending balance, shares at Mar. 31, 2018 | 15,530,527 | ||||
Beginning balance at Dec. 31, 2017 | 91,480 | $ 67,926 | 5,280 | 18,624 | (350) |
Beginning balance, shares at Dec. 31, 2017 | 13,190,527 | ||||
Net income | 10,489 | ||||
Ending balance at Sep. 30, 2018 | 124,975 | $ 91,009 | 5,887 | 29,112 | (1,033) |
Ending balance, shares at Sep. 30, 2018 | 15,770,576 | ||||
Beginning balance at Mar. 31, 2018 | 117,260 | $ 90,677 | 5,526 | 21,840 | (783) |
Beginning balance, shares at Mar. 31, 2018 | 15,530,527 | ||||
Net income | 3,791 | 3,791 | |||
Stock issued under stock offering, net of expenses | (64) | $ (64) | |||
Stock issued under stock-based compensation plans | 281 | $ 281 | |||
Stock issued under stock-based compensation plans, shares | 98,688 | ||||
Stock-based compensation | 194 | 194 | |||
Change in unrealized loss on securities available for sale net of reclassifications and tax effects | (69) | (69) | |||
Ending balance at Jun. 30, 2018 | 121,393 | $ 90,894 | 5,720 | 25,631 | (852) |
Ending balance, shares at Jun. 30, 2018 | 15,629,215 | ||||
Net income | 3,481 | 3,481 | |||
Stock issued under stock offering, net of expenses | (4) | $ (4) | |||
Stock issued under stock-based compensation plans | 119 | $ 119 | |||
Stock issued under stock-based compensation plans, shares | 141,361 | ||||
Stock-based compensation | 167 | 167 | |||
Change in unrealized loss on securities available for sale net of reclassifications and tax effects | (181) | (181) | |||
Ending balance at Sep. 30, 2018 | 124,975 | $ 91,009 | 5,887 | 29,112 | (1,033) |
Ending balance, shares at Sep. 30, 2018 | 15,770,576 | ||||
Beginning balance at Dec. 31, 2018 | 129,787 | $ 91,209 | 6,249 | 32,877 | (548) |
Beginning balance, shares at Dec. 31, 2018 | 15,860,306 | ||||
Net income | 4,740 | 4,740 | |||
Stock issued under stock-based compensation plans | 292 | $ 292 | |||
Stock issued under stock-based compensation plans, shares | 118,162 | ||||
Stock-based compensation | 377 | 377 | |||
Repurchase of common stock | (2,381) | $ (2,381) | |||
Repurchase of common stock, shares | (258,885) | ||||
Cash dividends declared | (793) | (793) | |||
Change in unrealized loss on securities available for sale net of reclassifications and tax effects | 354 | 354 | |||
Ending balance at Mar. 31, 2019 | 132,376 | $ 89,120 | 6,626 | 36,824 | (194) |
Ending balance, shares at Mar. 31, 2019 | 15,719,583 | ||||
Beginning balance at Dec. 31, 2018 | 129,787 | $ 91,209 | 6,249 | 32,877 | (548) |
Beginning balance, shares at Dec. 31, 2018 | 15,860,306 | ||||
Net income | 12,576 | ||||
Ending balance at Sep. 30, 2019 | 137,593 | $ 87,085 | 7,154 | 43,086 | 268 |
Ending balance, shares at Sep. 30, 2019 | 15,711,580 | ||||
Beginning balance at Mar. 31, 2019 | 132,376 | $ 89,120 | 6,626 | 36,824 | (194) |
Beginning balance, shares at Mar. 31, 2019 | 15,719,583 | ||||
Net income | 3,836 | 3,836 | |||
Stock issued under stock-based compensation plans, shares | 77,809 | ||||
Stock-based compensation | 339 | 339 | |||
Repurchase of common stock | (665) | $ (665) | |||
Repurchase of common stock, shares | (74,385) | ||||
Cash dividends declared | (782) | (782) | |||
Change in unrealized loss on securities available for sale net of reclassifications and tax effects | 378 | 378 | |||
Ending balance at Jun. 30, 2019 | 135,482 | $ 88,455 | 6,965 | 39,878 | 184 |
Ending balance, shares at Jun. 30, 2019 | 15,723,007 | ||||
Net income | 4,000 | 4,000 | |||
Stock issued under stock-based compensation plans | 72 | $ 72 | |||
Stock issued under stock-based compensation plans, shares | 145,190 | ||||
Stock-based compensation | 189 | 189 | |||
Repurchase of common stock | (1,442) | $ (1,442) | |||
Repurchase of common stock, shares | (156,617) | ||||
Cash dividends declared | (792) | (792) | |||
Change in unrealized loss on securities available for sale net of reclassifications and tax effects | 84 | 84 | |||
Ending balance at Sep. 30, 2019 | $ 137,593 | $ 87,085 | $ 7,154 | $ 43,086 | $ 268 |
Ending balance, shares at Sep. 30, 2019 | 15,711,580 |
CONSOLIDATED STATEMENTS OF CASH
CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) $ in Thousands | 9 Months Ended | ||
Sep. 30, 2019USD ($) | Sep. 30, 2018USD ($) | ||
Cash flows from operating activities | |||
Net income | $ 12,576 | $ 10,489 | |
Adjustments to reconcile net income to net cash and cash equivalents provided by operating activities: | |||
Provision for loan losses | 691 | 1,047 | |
Depreciation and amortization of premises and equipment | 835 | 762 | |
Amortization of net premiums on securities | 183 | 183 | |
Stock-based compensation | 905 | 606 | |
Gain on sales of loans | (4,379) | (3,852) | |
Earnings on company owned life insurance (COLI) | (1,445) | (231) | |
Origination of loans held for sale | (63,204) | (51,051) | |
Proceeds from sales of loans held for sale | 66,415 | 65,769 | |
Amortization of servicing assets | 1,581 | 1,295 | |
Net change in fair value of equity investment with readily determinable fair value | (137) | ||
Net change in: | |||
Accrued interest receivable | (73) | (319) | |
Deferred tax assets | 1,313 | (874) | |
Other assets | 129 | (2,402) | |
Accrued interest payable | 826 | 772 | |
Other liabilities | (307) | 1,177 | |
Net cash from operating activities | 15,909 | 23,371 | |
Cash flows from investing activities | |||
Net change in loans receivable | (91,815) | (102,630) | |
Proceeds from matured, called, or paid-down securities available for sale | 9,006 | 4,845 | |
Proceeds from COLI | 2,288 | ||
Purchase of securities available for sale | (4,989) | (13,262) | |
Purchase of equity investments | (1,000) | ||
Purchase of premises and equipment, net | (1,569) | (1,039) | |
Purchase of other investments | (776) | (416) | |
Net cash from investing activities | (88,855) | (112,502) | |
Cash flows from financing activities | |||
Net change in deposits | 90,817 | 123,585 | |
Cash received from stock option exercises | 364 | 514 | |
Repayment of Federal Home Loan Bank advances | (25,000) | ||
Issuance of common stock, net of expenses | 22,569 | ||
Repurchase of common stock | (4,488) | ||
Cash dividend paid on common stock | (2,366) | ||
Net cash from financing activities | 84,327 | 121,668 | |
Net change in cash and cash equivalents | 11,381 | 32,537 | |
Cash and cash equivalents at beginning of period | 77,726 | 63,250 | |
Cash and cash equivalents at end of period | 89,107 | 95,787 | |
Supplemental cash flow information | |||
Income taxes | 3,465 | 5,379 | |
Interest | 10,056 | 5,444 | |
Supplemental noncash disclosure: | |||
Transfer from loan receivable to OREO | 1,817 | ||
The adoption of ASU 2016-02, leases (Topic 842) recognition right-of-use assets | 8,606 | [1] | |
Transfer from securities available for sale to other investments | $ 2,486 | ||
ASU 2016-02 | |||
Supplemental noncash disclosure: | |||
The adoption of ASU 2016-02, leases (Topic 842) recognition right-of-use assets | $ 8,606 | ||
[1] | The adoption of ASU 2016-02, Leases (Topic 842) in the first quarter of 2019 resulted in the recognition of right-of-use assets and lease liabilities on balance sheet. |
Business Description
Business Description | 9 Months Ended |
Sep. 30, 2019 | |
Organization Consolidation And Presentation Of Financial Statements [Abstract] | |
Business Description | Note 1. Business Description OP Bancorp (the “Company”) is a California corporation whose common stock is quoted on the Nasdaq Global Market under the ticker symbol, “OPBK.” The Company was formed to acquire 100% of the voting equity of Open Bank (the “Bank”) and commenced operation as a bank holding company on June 1, 2016. This transaction was treated as an internal reorganization as all shareholders of the Bank became shareholders of the Company. The Company has no operations other than ownership of the Bank. The Bank is a California state-chartered and FDIC-insured financial institution, which began its operations on June 10, 2005. Headquartered in downtown Los Angeles, California, the Company operates primarily in the traditional banking business arena that includes accepting deposits and making loans and investments. The Company’s primary deposit products are demand and time deposits, and the primary lending products are commercial business loans to small to medium sized businesses. The Company is operating with nine full service branches, eight of which are located in California, in Downtown Los Angeles, Los Angeles Fashion District, Los Angeles Koreatown, Gardena, Buena Park and Santa Clara. The Company opened a ninth full service branch in Carrollton, Texas in April, 2019. The Company also has four loan production offices in Atlanta, Georgia, Aurora, Colorado, and Lynwood and Seattle, Washington . On March 27, 2018, the Company completed its initial public offering of common stock, pursuant to which an aggregate of 2,300,000 shares of its common stock were sold at a public offering price of $11.00 per share, for aggregate net proceeds of approximately $22.6 million, after deducting underwriter discounts and commissions paid by it of approximately $1.7 million and other offering expenses of approximately $925,000. |
Summary of Significant Accounti
Summary of Significant Accounting Policies | 9 Months Ended |
Sep. 30, 2019 | |
Accounting Policies [Abstract] | |
Summary of Significant Accounting Policies | Note 2. Summary of Significant Accounting Policies Basis of Presentation: The accompanying unaudited consolidated financial statements and notes thereto of the Company have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (“SEC”) for Form 10-Q and conform to practices within the banking industry and include all of the information and disclosures required by accounting principles generally accepted in the United States of America (“GAAP”) for interim financial reporting. The accompanying unaudited consolidated financial statements reflect all adjustments (consisting only of normal recurring adjustments), which are necessary for a fair presentation of financial results for the interim periods presented, including eliminating intercompany transactions and balances. The results of operations for the interim periods are not necessarily indicative of the results for the full year. These interim unaudited financial statements should be read in conjunction with the audited consolidated financial statements and the notes thereto as of and for the year ended December 31, 2018, included in the Companys’ Annual Report on Form 10-K for the year ended December 31, 2018. Use of Estimates: To prepare financial statements in conformity with GAAP, management makes estimates and assumptions based on available information. These estimates and assumptions affect the amounts reported in the financial statements and the disclosures provided, and actual results could differ. Concentration of Risk: Most of the Company’s customers are located within Los Angeles County and the surrounding area. The concentration of loans originated in this area may subject the Company to the risk of adverse impacts of economic, regulatory or other developments that could occur in Southern California. The Company has significant concentration in commercial real estate loans. The Company obtains what it believes to be sufficient collateral to secure potential losses. The extent and value of the collateral obtained varies based upon the details underlying each loan agreement. Reclassifications: Some items in the prior period financial statements were reclassified to conform to the current presentation. Reclassification had no effect on prior year net income or shareholders’ equity. There has been no significant or material changes to the Company’s accounting policies during the three months ended September 30, 2019, as compared to the Summary of Significant Accounting Policies as described in “Note 2 of the Notes to Consolidated Financial Statements” in the Company’s unaudited consolidated financial statements included in its Quarterly Report on Form 10-Q for the period ended June 30, 2019. Recent Accounting Pronouncements: In June 2016, the FASB issued ASU 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (ASU 2016-13). The objective of ASU 2016-13 is to provide financial statement users with decision-useful information about the expected credit losses on financial instruments and other commitments to extend credit. ASU 2016-13 includes provisions that require financial assets measured at amortized cost (such as loans and held to maturity (HTM) debt securities) to be presented at the net amount expected to be collected. This will be accomplished through recognition of an estimate of all current expected credit losses. The estimate will include forecasted information for the timeframe that an entity is able to develop reasonable and supportable forecasts. This is a change from the current practice of recognizing incurred losses based on the probable initial recognition threshold under current GAAP. In addition, credit losses on available for sale (AFS) debt securities will be recorded through an allowance for credit losses rather than as a write-down. Under ASU 2016-13, an entity will be able to record reversals of credit losses in current period income when the estimate of credit losses declines, whereas current GAAP prohibits reflecting those improvements in current period earnings. ASU 2016-13 is effective for annual periods and interim periods within those annual periods beginning after December 15, 2019, initially, and early adoption is permitted for fiscal years, including interim periods, beginning after December 15, 2018. ASU 2016-13 will be applied through a cumulative effect adjustment to retained earnings (modified-retrospective approach), except for debt securities for which an other-than-temporary impairment had been recognized before the effective date. A prospective transition approach is required for these debt securities. The Company is currently evaluating the effects of ASU 2016-13 on its financial statements and disclosures, including software solutions, data requirements and loss estimation methodologies. The company has engaged a third party advisor to develop a new expected loss model. While the effects cannot yet be quantified, the Company expects ASU 2016-13 to add complexity and costs to its current credit loss evaluation process. On July 2019, FASB proposed the effective date delay to January 2020 for SEC filers, excluding smalller reporting companies (SRCs), and January 2023 for all other entities including SRCs, and on October 2019, FASB voted to approve the proposed delay. The Board will draft a final ASU for vote by written ballot. The Compnay expects the adoption date would be January 2023. In August 2018, the FASB issued ASU 2018-13, “Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement”. ASU 2018-13 adds, modifies, and removes disclosure requirements for fair value measurements. ASU 2018-13 is effective annual periods in fiscal years beginning after December 15, 2019, including interim periods within those annual periods. Early adoption is permitted upon the issuance of ASU 2018-13. The Company does not expect this ASU to have a material impact on its financial statements and disclosures. In February 2016, the FASB issued its new lease accounting guidance in ASU No. 2016-02, Leases (Topic 842) Codification Improvements to Topic 842, Leases Leases (Topic 842): Targeted Improvements In March 2017, the FASB issued ASU 2017-08, Receivables—Nonrefundable Fees and Other Costs (Subtopic 310-20) (ASU 2017-08). ASU 2017-08 amends the amortization period for certain purchased callable debt securities held at a premium. Prior to the issuance of this guidance, premiums were amortized as an adjustment of yield over the contractual life of the instrument. ASU 2017-08 requires premiums on purchased callable debt securities that have explicit, noncontingent call features that are callable at fixed prices to be amortized to the earliest call date. There are no accounting changes for securities held at a discount. This ASU is effective for annual periods and interim periods within those annual periods beginning after December 15, 2018, and early adoption is permitted. ASU 2017-08 will be applied through a cumulative effect adjustment through equity (modified-retrospective approach). The Company did not have callable debt securities held at a premium at December 31, 2018 or September 30, 2019. |
Securities
Securities | 9 Months Ended |
Sep. 30, 2019 | |
Investments Debt And Equity Securities [Abstract] | |
Securities | Note 3. Securities The following table summarizes the amortized cost, fair value, and the corresponding amounts of gross unrealized gains and losses for available for sale securities as of September 30, 2019 and December 31, 2018: Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value As of September 30, 2019: (Dollars in thousands) Available for sale: U.S. Government sponsored agency securities $ 5,998 $ — $ (6 ) $ 5,992 Mortgage-backed securities: residential 12,160 61 (24 ) 12,197 Collateralized mortgage obligations: residential 33,757 395 (46 ) 34,106 Total available for sale $ 51,915 $ 456 $ (76 ) $ 52,295 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value As of December 31, 2018: (Dollars in thousands) Available for sale: U.S. Government sponsored agency securities $ 6,994 $ — $ (88 ) $ 6,906 Mortgage-backed securities: residential 14,465 — (336 ) 14,129 Collateralized mortgage obligations: residential 34,655 156 (510 ) 34,301 Total available for sale $ 56,114 $ 156 $ (934 ) $ 55,336 There were no sales of securities available for sale in the three or nine months ended September 30, 2019 or 2018. The amortized cost and estimated fair value of securities available for sale at September 30, 2019, by contractual maturity, are shown below. Securities without a contractual maturity are shown separately. Amortized Cost Fair Value As of September 30, 2019: (Dollars in thousands) Available for sale: Within one year $ 3,998 $ 3,995 One to five years 2,000 1,997 Mortgage-backed securities: residential 12,160 12,197 Collateralized mortgage obligations 33,757 34,106 Total available for sale $ 51,915 $ 52,295 Expected maturities may differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties. At September 30, 2019 and December 31, 2018, there were no holdings of securities of any one issuer, other than the U.S. Government and its agencies, in an amount greater than 10% of shareholders’ equity. The following table summarizes securities with unrealized losses as of September 30, 2019 and December 31, 2018, aggregated by length of time in a continuous unrealized loss position: Less Than 12 Months 12 Months or Longer Total Fair Value Unrealized Losses Fair Value Unrealized Losses Fair Value Unrealized Losses As of September 30, 2019: (Dollars in thousands) Available for sale: U.S. Government sponsored agency securities $ 1,000 $ — $ 3,992 $ (6 ) $ 4,992 $ (6 ) Mortgage-backed securities: residential 1,176 — 3,442 (24 ) 4,618 (24 ) Collateralized mortgage obligations 2,140 (14 ) 4,014 (32 ) 6,154 (46 ) Total available for sale $ 4,316 $ (14 ) $ 11,448 $ (62 ) $ 15,764 $ (76 ) Less Than 12 Months 12 Months or Longer Total Fair Value Unrealized Losses Fair Value Unrealized Losses Fair Value Unrealized Losses As of December 31, 2018: (Dollars in thousands) Available for sale: U.S. Government sponsored agency securities $ — $ — $ 6,906 $ (88 ) $ 6,906 $ (88 ) Mortgage-backed securities: residential 3,209 (23 ) 10,920 (313 ) 14,129 (336 ) Collateralized mortgage obligations 3,348 (26 ) 14,544 (484 ) 17,892 (510 ) Total available for sale $ 6,557 $ (49 ) $ 32,370 $ (885 ) $ 38,927 $ (934 ) The Company believes that the unrealized losses are temporary, arising mainly from fluctuations in interest rates and do not reflect a deterioration of credit quality of the issuers. In analyzing an issuer’s financial condition, the Company may consider whether the securities are issued by the federal government or its agencies, whether downgrades by bond rating agencies have occurred, and the results of reviews of the issuer’s financial condition. The fair value is expected to recover as the securities approach maturity. Management does not intend to sell and it is likely that management will not be required to sell the securities prior to their anticipated recovery. Management evaluates securities for other-than-temporary impairment (“OTTI”) on at least a quarterly basis, and more frequently when economic or market conditions warrant such an evaluation. For securities in an unrealized loss position, management considers the extent and duration of the unrealized loss, and the financial condition and near-term prospects of the issuer. Management also assesses whether it intends to sell, or it is more likely than not that it will be required to sell, a security in an unrealized loss position before recovery of its amortized cost basis. If either of the criteria regarding intent or requirement to sell is met, the entire difference between amortized cost and fair value is recognized as impairment through earnings. For debt securities that do not meet the aforementioned criteria, the amount of impairment is split into two components as follows: 1) OTTI related to credit loss, which must be recognized in the income statement, and 2) OTTI related to other factors, which is recognized in other comprehensive income. The credit loss is defined as the difference between the present value of the cash flows expected to be collected and the amortized cost basis. As of September 30, 2019, management believes no securities with unrealized losses were OTTI. There were no securities pledged as collateral as of September 30, 2019 or December 31, 2018. Other investments as of September 30, 2019 and December 31, 2018, consisted of the following: September 30, 2019 December 31, 2018 (Dollars in thousands) FHLB stock $ 5,358 $ 4,582 PCBB stock 190 190 Mutual fund - CRA qualified 3,625 2,488 Total other investments $ 9,173 $ 7,260 |
Loans
Loans | 9 Months Ended |
Sep. 30, 2019 | |
Receivables [Abstract] | |
Loans | Note 4. Loans The composition of the loan portfolio was as follows at September 30, 2019 and December 31, 2018: September 30, 2019 December 31, 2018 (Dollars in thousands) Real estate: Commercial real estate $ 594,447 $ 503,834 SBA loans—real estate 124,963 117,834 Total real estate 719,410 621,668 SBA loans—non-real estate 11,269 9,541 Commercial and industrial 107,730 113,975 Home mortgage 123,092 127,298 Consumer 2,869 2,577 Gross loans receivable 964,370 875,059 Allowance for loan losses (9,640 ) (9,636 ) Loans receivable, net $ 954,730 $ 865,423 No loans were outstanding to related parties as of September 30, 2019 or December 31, 2018. The activity in the allowance for loan losses for the three and nine months ended September 30, 2019 and 2018 was as follows: SBA Commercial SBA Loans Loans Non- Commercial Home Real Estate Real Estate Real Estate and Industrial Mortgage Consumer Total (Dollars in thousands) Three months ended September 30, 2019: Beginning balance $ 5,554 $ 933 $ 119 $ 1,266 $ 1,609 $ 44 $ 9,525 Provision for loan losses 102 — (2 ) 171 26 (7 ) 290 Charge-offs — — — (175 ) — — (175 ) Recoveries — — — — — — — Ending balance $ 5,656 $ 933 $ 117 $ 1,262 $ 1,635 $ 37 $ 9,640 Three months ended September 30, 2018: Beginning balance $ 4,804 $ 978 $ 536 $ 1,877 $ 1,489 $ 39 $ 9,723 Provision for loan losses 271 30 89 43 12 (6 ) 439 Charge-offs — — (57 ) (565 ) — — (622 ) Recoveries — — 6 5 — — 11 Ending balance $ 5,075 $ 1,008 $ 574 $ 1,360 $ 1,501 $ 33 $ 9,551 SBA Commercial SBA Loans Loans Non- Commercial Home Real Estate Real Estate Real Estate and Industrial Mortgage Consumer Total (Dollars in thousands) Nine months ended September 30, 2019: Beginning balance $ 4,805 $ 894 $ 505 $ 1,746 $ 1,653 $ 33 $ 9,636 Provision for loan losses 851 59 (388 ) 184 (18 ) 3 691 Charge-offs — (20 ) — (668 ) — — (688 ) Recoveries — — — — — 1 1 Ending balance $ 5,656 $ 933 $ 117 $ 1,262 $ 1,635 $ 37 $ 9,640 Nine months ended September 30, 2018: Beginning balance $ 4,801 $ 1,082 $ 538 $ 1,265 $ 1,408 $ 45 $ 9,139 Provision for loan losses 274 (74 ) 112 654 93 (12 ) 1,047 Charge-offs — — (85 ) (565 ) — — (650 ) Recoveries — — 9 6 — — 15 Ending balance $ 5,075 $ 1,008 $ 574 $ 1,360 $ 1,501 $ 33 $ 9,551 The following table presents the balance in the allowance for loan losses and the recorded investment in loans by portfolio segment as of September 30, 2019 and December 31, 2018: Loans Individually Evaluated for Impairment Loans Collectively Evaluated for Impairment Total As of September 30, 2019: (Dollars in thousands) Allowance for loan losses: Commercial real estate $ — $ 5,656 $ 5,656 SBA loans—real estate — 933 933 SBA loans—non-real estate — 117 117 Commercial and industrial 336 926 1,262 Home mortgage — 1,635 1,635 Consumer — 37 37 Total $ 336 $ 9,304 $ 9,640 Loans: Commercial real estate $ — $ 595,903 $ 595,903 SBA loans—real estate 488 125,085 125,573 SBA loans—non-real estate 36 11,295 11,331 Commercial and industrial 336 107,646 107,982 Home mortgage — 123,581 123,581 Consumer — 2,875 2,875 Total $ 860 $ 966,385 $ 967,245 As of December 31, 2018: Allowance for loan losses: Commercial real estate $ — $ 4,805 $ 4,805 SBA loans—real estate — 894 894 SBA loans—non-real estate 362 143 505 Commercial and industrial 836 910 1,746 Home mortgage — 1,653 1,653 Consumer — 33 33 Total $ 1,198 $ 8,438 $ 9,636 Loans: Commercial real estate $ — $ 505,229 $ 505,229 SBA loans—real estate 834 117,159 117,993 SBA loans—non-real estate 57 9,875 9,932 Commercial and industrial 1,516 112,781 114,297 Home mortgage — 127,806 127,806 Consumer — 2,586 2,586 Total $ 2,407 $ 875,436 $ 877,843 The following table presents information related to impaired loans by class of loans as of and for the three and nine months ended September 30, 2019 and 2018. The difference between the unpaid principal balance (net of partial charge-offs) and the recorded investment in the loans is not considered to be material. The difference between interest income recognized and cash basis interest recognized was immaterial. Average Interest Recorded Allowance Recorded Income Investment Allocated Investment Recognized As of and for the three months ended September 30, 2019: (Dollars in thousands) With no related allowance recorded: SBA loans—real estate $ 488 $ — $ 493 $ — SBA loans—non-real estate 36 — 28 — With an allowance recorded: Commercial and industrial 336 336 337 5 Total $ 860 $ 336 $ 858 $ 5 As of and for the three months ended September 30, 2018: With no related allowance recorded: SBA loans—real estate $ 134 $ — $ 138 $ — Commercial and industrial 748 — 749 11 With an allowance recorded: SBA loans—non-real estate 434 434 434 — Commercial and industrial 345 345 348 5 Total $ 1,661 $ 779 $ 1,669 $ 16 Average Interest Recorded Allowance Recorded Income Investment Allocated Investment Recognized As of and for the nine months ended September 30, 2019: (Dollars in thousands) With no related allowance recorded: SBA loans—real estate $ 488 $ — $ 505 $ — SBA loans—non-real estate 36 — 46 — With an allowance recorded: Commercial and industrial 336 336 339 15 Total $ 860 $ 336 $ 890 $ 15 As of and for the nine months ended September 30, 2018: With no related allowance recorded: Home mortgage $ 134 $ — $ 137 $ — Consumer 748 — 749 33 With an allowance recorded: SBA loans—non-real estate 434 434 443 — Commercial and industrial 345 345 350 14 Total $ 1,661 $ 779 $ 1,679 $ 47 The following table presents the recorded investment in nonaccrual loans and loans past due greater than 90 days still accruing interest, by class of loans, as of September 30, 2019 and December 31, 2018: Nonaccrual Loans >90 Days Past Due & Still Accruing Total As of September 30, 2019: (Dollars in thousands) SBA loans—real estate $ 488 $ — $ 488 SBA loans—non-real estate 36 — 36 Commercial and industrial 710 — 710 Total $ 1,234 $ — $ 1,234 As of December 31, 2018: SBA loans—real estate $ 834 $ — $ 834 SBA loans—non-real estate 57 — 57 Commercial and industrial 680 — 680 Total $ 1,571 $ — $ 1,571 Nonaccrual loans and loans past due greater than 90 days still accruing interest include both smaller balance homogeneous loans that are collectively evaluated for impairment and individually classified impaired loans. The following table represents the aging of the recorded investment in past due loans as of September 30, 2019 and December 31, 2018: 30-59 Days Past Due 60-89 Days Past Due > 90 Days Past Due Total Past Due Loans Not Past Due Total As of September 30, 2019: (Dollars in thousands) Commercial real estate $ 472 $ — $ — $ 472 $ 595,431 $ 595,903 SBA—real estate 1,293 580 — 1,873 123,700 125,573 SBA—non-real estate 3 — — 3 11,328 11,331 Commercial and industrial 374 — — 374 107,608 107,982 Home mortgage 437 — 710 1,147 122,434 123,581 Consumer — — — — 2,875 2,875 $ 2,579 $ 580 $ 710 $ 3,869 $ 963,376 $ 967,245 As of December 31, 2018: Commercial real estate $ — $ — $ — $ — $ 505,229 $ 505,229 SBA—real estate — — 311 311 117,682 117,993 SBA—non-real estate — — — — 9,932 9,932 Commercial and industrial — — 680 680 113,617 114,297 Home mortgage 449 — — 449 127,357 127,806 Consumer — — — — 2,586 2,586 $ 449 $ — $ 991 $ 1,440 $ 876,403 $ 877,843 Troubled Debt Restructurings Modifications made were primarily extensions of existing payment modifications on loans previously identified as troubled debt restructurings. There were no new loans identified as trouble debt restructurings during the three and nine months ended September 30, 2019 or 2018. There were no payment defaults during the three and nine months ended September 30, 2019 or 2018 of loans that had been modified as troubled debt restructurings within the previous twelve months. Credit Quality Indicators Special Mention—Loans classified as special mention have a potential weakness that deserves management’s close attention. If left uncorrected, these potential weaknesses may result in deterioration of the repayment prospects for the loan or of the Company’s credit position at some future date. Substandard—Loans classified as substandard are inadequately protected by the current net worth and paying capacity of the obligor or of the collateral pledged, if any. Loans so classified have a well-defined weakness or weaknesses that jeopardize the liquidation of the debt. They are characterized by the distinct possibility that the institution will sustain some loss if the deficiencies are not corrected. Doubtful—Loans classified as doubtful have all the weaknesses inherent in those classified as substandard, with the added characteristic that the weaknesses make collection or liquidation in full, on the basis of currently existing facts, conditions, and values, highly questionable and improbable. Loans not meeting the criteria above that are analyzed individually as part of the above described process are considered to be pass-rated loans. As of September 30, 2019 and December 31, 2018, and based on the most recent analysis performed, the risk category of loans by class of loans is as follows: Pass Special Mention Substandard Doubtful Total As of September 30, 2019: (Dollars in thousands) Commercial real estate $ 595,903 $ — $ — $ — $ 595,903 SBA loans—real estate 122,553 773 2,247 — 125,573 SBA loans—non-real estate 11,281 14 36 — 11,331 Commercial and industrial 106,379 893 710 — 107,982 Home mortgage 123,325 — 256 — 123,581 Consumer 2,875 — — — 2,875 $ 962,316 $ 1,680 $ 3,249 $ — $ 967,245 As of December 31, 2018: Commercial real estate $ 505,229 $ — $ — $ — $ 505,229 SBA loans—real estate 115,993 — 2,000 — 117,993 SBA loans—non-real estate 9,859 16 57 — 9,932 Commercial and industrial 112,781 — 1,516 — 114,297 Home mortgage 127,806 — — — 127,806 Consumer 2,586 — — — 2,586 $ 874,254 $ 16 $ 3,573 $ — $ 877,843 |
Leases
Leases | 9 Months Ended |
Sep. 30, 2019 | |
Leases [Abstract] | |
Leases | Note 5. Leases On January 1, 2019, the Company adopted ASU No. 2016-02, Leases (Topic 842) , using the optional transition method permitted by ASU No. 2018-11, Leases (Topic 842): Targeted Improvements . The Company’s operating leases are real estate leases which are comprised of its headquarters and office facilities from nonaffiliated parties with remaining lease terms ranging from 1 to 10 years as of September 30, 2019. Certain lease arrangements contain extension option which are typically around 5 years. As these extension options are not generally considered reasonably certain of exercise, they are not included in the lease term. At September 30, 2019, operating right-of-use (“ROU”) assets and related liabilities were $8.6 million and $10.3 million, respectively. Short-term operating leases, which are defined as leases with term of twelve months or less, were not recognized as ROU assets with related lease liabilities as permitted under ASU No. 2016-02. The lease payments on short-term operating leases are immaterial. The Company did not have any finance leases at September 30, 2019. Operating lease ROU assets represent the Company’s right to use the underlying asset during the lease term and operating lease liabilities represent the Company’s obligation to make lease payments arising from the lease. ROU assets and operating lease liabilities are recognized at the lease commencement based on the present value of the remaining lease payments using the Company’s incremental borrowing rate at the lease commencement date. Operating lease expense, which is comprised of amortization of the ROU asset and the implicit interest accreted on the operating lease liability, is recognized on a straight-line basis over the lease term and is recorded in occupancy expense in the consolidated statements of income. The Company’s occupancy expense also includes variable lease costs which is comprised of the Company's share of actual costs for utilities, common area maintenance, property taxes, and insurance that are not included in lease liabilities and are expensed as incurred. Variable lease costs can also include rent escalations based on changes to indices, such as the Consumer Price Index, where the Company estimates future rent increases and records the actual difference to variable costs. The table below summarized the Company’s total lease cost: Three Months Ended Nine Months Ended (Dollars in thousands) September 30, 2019 September 30, 2019 Operating lease cost $ 444 $ 1,287 Variable lease cost 211 548 Total lease cost $ 655 $ 1,835 The table below summarizes other information related to the Company’s operating leases: Three Months Ended Nine Months Ended (Dollars in thousands) September 30, 2019 September 30, 2019 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 493 $ 1,408 Weighted average remaining lease term - operating leases 6.0 years Weighted average discount rate - operating leases 2.98 % Rent expense was $655,000 and $545,000 for the three months ended September 30, 2019 and 2018, respectively, and $1.8 million and $1.6 million for the nine months ended September 30, 2019 and 2018, respectively. The table below summarizes the remaining contractually obligated lease payments and a reconciliation to the lease liability reported on the consolidated balance sheet as of September 30, 2019: (Dollars in thousands) September 30, 2019 2019 remaining $ 301 2020 2,002 2021 2,032 2022 2,028 2023 1,816 Thereafter 3,343 Total lease payments 11,522 Discount to present value (1,187 ) Total lease liability $ 10,335 Rent commitments related to the lease of the Company’s main office and branch facilities, before considering renewal options and additional lessor charges as of December 31, 2018, were as follows: (Dollars in thousands) December 31, 2018 2019 $ 1,709 2020 1,757 2021 1,742 2022 1,685 2023 1,455 Thereafter 2,669 Total $ 11,017 |
Premises and Equipment
Premises and Equipment | 9 Months Ended |
Sep. 30, 2019 | |
Property Plant And Equipment [Abstract] | |
Premises and Equipment | Note 6. Premises and equipment The Company’s premises and equipment consisted of the following as of September 30, 2019 and December 31, 2018: September 30, 2019 December 31, 2018 (Dollars in thousands) Leasehold improvements $ 6,505 $ 5,518 Furniture and fixtures 3,155 2,791 Equipment and others 2,329 2,111 Total cost 11,989 10,420 Accumulated depreciation (6,622 ) (5,787 ) Net book value $ 5,367 $ 4,633 Total depreciation expense included in occupancy and equipment expenses was $297,000 and $273,000 for the three months ended September 30, 2019 and 2018, respectively, and $835,000 and $762,000 for the nine months ended September 30, 2019 and 2018, |
Servicing Assets
Servicing Assets | 9 Months Ended |
Sep. 30, 2019 | |
Servicing Asset [Abstract] | |
Servicing Assets | Note 7. Servicing Assets Activity for loan servicing assets during the three and nine months ended September 30, 2019 and 2018 is as follows: Three Months Ended September 30, Nine Months Ended September 30, 2019 2018 2019 2018 (Dollars in thousands) Beginning balance $ 6,996 $ 6,994 $ 6,987 $ 6,771 Additions 552 588 1,553 1,621 Amortized to expense (589 ) (485 ) (1,581 ) (1,295 ) Ending balance $ 6,959 $ 7,097 $ 6,959 $ 7,097 There was no valuation allowance recorded against the carrying value of the servicing assets as of September 30, 2019 or 2018. The fair value of the servicing assets was $8.3 million at September 30, 2019, which was determined using discount rates ranging from 1.8% to 10.0% and prepayment speeds ranging from 13.4% to 14.6%, depending on the stratification of the specific assets. The fair value of the servicing assets was $8.6 million at September 30, 2018, which was determined using discount rates ranging from 4.7% to 11.0% and prepayment speeds ranging from 11.4% to 13.3%, depending on the stratification of the specific assets. |
Deposits
Deposits | 9 Months Ended |
Sep. 30, 2019 | |
Banking And Thrift [Abstract] | |
Deposits | Note 8. Deposits The scheduled maturities of time deposits were as follows as of September 30, 2019: September 30, 2019 (Dollars in thousands) 2019 remaining $ 124,973 2020 288,900 2021 5,458 2022 972 2023 724 Thereafter 121 Total $ 421,148 Deposits from principal officers, directors, and their affiliates as of September 30, 2019 and December 31, 2018 were $1.10 million and $778,000, respectively. |
Borrowing Arrangements
Borrowing Arrangements | 9 Months Ended |
Sep. 30, 2019 | |
Debt Disclosure [Abstract] | |
Borrowing Arrangements | Note 9. Borrowing arrangements As of September 30, 2019, the Company had no The Company had available borrowings from the following institutions as of September 30, 2019: September 30, 2019 (Dollars in thousands) Federal Home Loan Bank—San Francisco $ 232,865 Federal Reserve Bank 120,289 Pacific Coast Bankers Bank 8,000 Zions Bank 5,500 Total $ 366,654 The Company has pledged approximately $811.5 million of loans as collateral for these lines of credit as of September 30, 2019. |
Income Taxes
Income Taxes | 9 Months Ended |
Sep. 30, 2019 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | Note 10. Income Taxes The Company’s income tax expense was $1.2 million and $1.1 million for the three months ended September 30, 2019 and 2018, respectively, and $4.0 million and $3.8 million for the nine months ended September 30, 2019 ad 2018, respectively. The effective income tax rate was 23.6% and 24.7% for the three months ended September 30, 2019 and 2018, respectively, and 24.1% and 26.5% for the nine months ended September 30, 2019 and 2018, respectively. The Company is subject to U.S. Federal income tax as well as various state taxing jurisdictions. The Company is no longer subject to examination by Federal taxing authorities for tax years prior to 2016 and for state taxing authorities for tax years prior to 2015. There were no significant unrealized tax benefits recorded as of September 30, 2019 and 2018, and the Company does not expect any significant increase in unrealized tax benefits in the next twelve months. |
Commitments and Contingencies
Commitments and Contingencies | 9 Months Ended |
Sep. 30, 2019 | |
Commitments And Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | Note 11. Commitments and Contingencies Off-Balance-Sheet Credit Risk The Company evaluates the creditworthiness of each customer. Collateral, if deemed necessary by the Company upon the extension of credit, is obtained based on management’s evaluation of the borrower. Collateral for commercial and industrial loans may vary, but may include securities, accounts receivable, inventory, property, plant and equipment, and income producing commercial or other properties. The following table shows the distribution of undisbursed loan commitments as of the dates indicated: September 30, 2019 December 31, 2018 (Dollars in thousands) Commitments to extend credit $ 76,094 $ 60,789 Standby letter of credit 3,983 1,790 Commercial letter of credit 973 1,209 Total undisbursed loan commitments $ 81,050 $ 63,788 The majority of these off-balance sheet commitments have a variable interest rate. Management does not anticipate any material losses as a result of these transactions. |
Stock-based Compensation
Stock-based Compensation | 9 Months Ended |
Sep. 30, 2019 | |
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract] | |
Stock-based Compensation | Note 12. Stock-based Compensation The Company has two stock-based compensation plans currently in effect as of September 30, 2019, as described further below. Total compensation cost that has been charged against earnings for these plans was $189,000 and $167,000 in the three months ended September 30, 2019 and 2018, respectively, and $905,000 and $606,000 for the nine months ended September 30, 2019 and 2018, respectively. 2005 Plan The exercise prices of the options may not be less than 100 percent of the fair value of the Company’s common stock at the date of grant. The options, when granted, vest either immediately or ratably over five years from the date of the grant and expire after ten years if not exercised. The 2005 plan was expired in 2015 and no share is available for grant. A summary of the transactions under the 2005 Plan for the nine months ended September 30, 2019 is as follows: Weighted Number of Average Aggregate Options Exercise Intrinsic Outstanding Price Value (Dollars in thousands, except per share data) Outstanding, as of January 1, 2019 250,000 $ 4.00 Options granted — — Options exercised (95,000 ) 2.20 Options forfeited — — Options expired — — Outstanding, as of September 30, 2019 155,000 4.70 $ 787 Fully vested and expected to vest 155,000 4.70 $ 787 Vested 155,000 $ 4.70 $ 787 Information related to the 2005 Plan for the periods indicated follows: Three Months Ended September 30, Nine Months Ended September 30, 2019 2018 2019 2018 (Dollars in thousands) Intrinsic value of options exercised $ 206 $ 234 $ 593 $ 487 Cash received from option exercises 72 119 179 195 Tax benefit realized from option exercised 5 — 5 — The weighted average remaining contractual term of stock options outstanding under the 2005 Plan at September 30, 2019 was 2.77 years. The weighted average remaining contractual term of stock options that were exercisable at September 30, 2019 was 2.77 years. All of the stock options that are outstanding under the 2005 Plan were fully vested as of September 30, 2019. 2010 Plan The exercise prices of stock options granted under the plan may not be less than 100% of the fair value of the Company’s stock at the date of grant. The options, when granted, vest ratably over five years from the date of the grant and expire after ten years if not exercised. There were no stock options granted under the 2010 Plan during the nine months ended September 30, 2019 or 2018. Restricted stock awards issued under the 2010 Plan may or may not be subject to vesting provisions. Awards which were granted in the nine months ended September 30, 2019 and 2018 vest at the end of three years from the date of the grant. In the nine months ended September 30, 2019 and 2018, 3,000 shares were granted at weighted average fair value of $8.15 and 148,000 shares were granted at weighted average fair value of $12.7, respectively. Owners of the restricted stock awards shall have all of the rights of a shareholder including the right to vote the shares and to all dividends (cash or stock). Compensation expense related to restricted stock awards will be recognized over the vesting period of the awards based on the fair value of the Company’s common stock at the issue date. A summary of stock options outstanding under the 2010 Plan for the nine months ended September 30, 2019 is as follows: Weighted Number of Average Aggregate Options Exercise Intrinsic Outstanding Price Value (Dollars in thousands, except per share data) Outstanding, as of January 1, 2019 620,000 $ 4.57 Options granted — — Options exercised (165,000 ) 1.12 Options forfeited — — Options expired — — Outstanding, as of September 30, 2019 455,000 5.20 $ 2,085 Fully vested and expected to vest 440,000 5.10 $ 2,058 Vested 395,000 $ 4.77 $ 1,978 Information related to stock options exercised under the 2010 Plan for the periods indicated follows: Three Months Ended September 30, Nine Months Ended September 30, 2019 2018 2019 2018 (Dollars in thousands) Intrinsic value of options exercised $ — $ — $ 1,090 $ 876 Cash received from option exercises — — 185 319 Tax benefit realized from option exercised — — 285 160 The weighted average remaining contractual term of stock options outstanding under the 2010 Plan at September 30, 2019 was 2.59 years. The weighted average remaining contractual term of stock options that were exercisable at September 30, 2019 was 2.30 years. A summary of the changes in the Company’s non-vested restricted stock awards under the 2010 Plan for the nine months ended September 30, 2019 is as follows: Shares Issued Weighted Average Grant Date Fair Value Aggregate Intrinsic Value (Dollars in thousands, except share data) Non-vested, as of January 1, 2019 436,000 $ 8.19 Awards granted 3,000 8.15 Awards vested (141,500 ) 5.91 Awards forfeited (8,000 ) 10.10 Non-vested, as of September 30, 2019 289,500 $ 9.25 $ 2,831 Information related to non-vested restricted stock awards under the 2010 Plan for the periods indicated follows: Three Months Ended September 30, Nine Months Ended September 30, 2019 2018 2019 2018 (Dollars in thousands) Tax benefit realized from awards vested $ 141 $ 272 $ 144 $ 285 There were 95,427 shares available for grant under the 2010 Plan as of September 30, 2019 (in either stock options or restricted stock awards). As of September 30, 2019, the Company had approximately $1.9 million of unrecognized compensation cost related to unvested stock options and restricted stock awards under the 2010 Plan. The Company expects to recognize these costs over a weighted average period of 1.20 years. |
Employee Benefit Plan
Employee Benefit Plan | 9 Months Ended |
Sep. 30, 2019 | |
Compensation And Retirement Disclosure [Abstract] | |
Employee Benefit Plan | Note 13. Employee Benefit Plan The Company established a 401(k) profit sharing plan (the “401(k) Plan”) which is open to all eligible employees who are at least 21 years old and have completed 90 days of service. Each employee is allowed to contribute to the 401(k) Plan up to the maximum percentage allowable, not to exceed the limits of applicable IRS Code Sections. Each year, the Company may, in its discretion, make matching contributions to the 401(k) Plan. Total employer contributions to the 401(k) Plan amounted to $449,000 and $356,000 for the nine months ended September 30, 2019 and 2018, respectively. |
Revenue Recognition
Revenue Recognition | 9 Months Ended |
Sep. 30, 2019 | |
Revenue From Contract With Customer [Abstract] | |
Revenue Recognition | Note 14. Revenue Recognition Accounting Standards Codification ("ASC") 606, Revenue from Contracts with Customers ("ASC 606"), establishes principles for reporting information about the nature, amount, timing and uncertainty of revenue and cash flows arising from the entity's contracts to provide goods or services to customers. The core principle requires an entity to recognize revenue to depict the transfer of goods or services to customers in an amount that reflects the consideration that it expects to be entitled to receive in exchange for those goods or services recognized as performance obligations are satisfied. The majority of the Company’s revenue-generating transactions are not subject to ASC 606, including revenue generated from financial instruments, such as loans, letters of credit, and investment securities, as well as revenue related to mortgage servicing activities and revenue on bank owned life insurance, as these activities are subject to other GAAP discussed elsewhere within the disclosures. Descriptions of the Company’s revenue-generating activities that are within the scope of ASC 606, which are presented in the Company’s income statements as components of noninterest income are as follows: Service charges on deposits Wire transfer fee income: Other revenue streams that are recorded in other income in noninterest income include revenue generated from letters of credit and income on bank owned life insurance. These revenue streams are either not material or out of scope of ASC 606. |
Fair Value of Financial Instrum
Fair Value of Financial Instruments | 9 Months Ended |
Sep. 30, 2019 | |
Fair Value Disclosures [Abstract] | |
Fair Value of Financial Instruments | Note 15. Fair Value of Financial Instruments Fair value is the exchange price that would be received for an asset or paid to transfer a liability (exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. There are three levels of inputs that may be used to measure fair values: Level 1—Quoted prices (unadjusted) for identical assets or liabilities in active markets that the entity has the ability to access as of the measurement date. Level 2—Significant other observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data. Level 3—Significant unobservable inputs that reflect a company’s own assumptions about the assumptions that market participants would use in pricing an asset or liability. The Company used the following methods and significant assumptions to estimate fair value: Securities Available for Sale Other Investment Impaired Loans Appraisals for collateral-dependent impaired loans are performed by certified general appraisers (for commercial properties) or certified residential appraisers (for residential properties) whose qualifications and licenses have been reviewed and verified by the Company. Once received, a member of the credit department reviews the assumptions and approaches utilized in the appraisal as well as the overall resulting fair value in comparison with independent data sources such as recent market data or industry-wide statistics. Assets and liabilities measured at fair value on a recurring basis as of September 30, 2019 and December 31, 2018 are summarized below: Fair Value Measuring Using Quoted Significant Other Significant Prices in Observable Unobservable Total Active Markets Inputs Inputs Fair Value (Level 1) (Level 2) (Level 3) (Dollars in thousands) As of September 30, 2019 : U.S. Government sponsored agency securities $ 5,992 $ — $ 5,992 $ — Mortgage-backed securities - residential 12,197 — 12,197 — Collateralized mortgage obligations 34,106 — 34,106 — Other investments: Mutual fund - CRA qualified 3,625 3,625 — — As of December 31, 2018 : U.S. Government sponsored agency securities $ 6,906 $ — $ 6,906 $ — Mortgage-backed securities - residential 14,129 — 14,129 — Collateralized mortgage obligations 34,301 — 34,301 — Other investments: Mutual fund - CRA qualified 2,488 2,488 — — There were no transfers between Level 1 and Level 2 in the nine months ended September 30, 2019 or 2018. There were no other assets or liabilities, except OREO measured at fair value on a non-recurring basis as of September 30, 2019 or December 31, 2018. OREO is reported at fair value. The value was based on third party appraisal, which the Company classifies as a Level 3 nonrecurring fair value measurement. Financial Instruments Carrying Amount Level 1 Level 2 Level 3 Value As of September 30, 2019: (Dollars in thousands) Financial Assets: Cash and cash equivalents $ 89,107 $ 89,107 $ — $ — $ 89,107 Loans held for sale 368 — 397 — 397 Loans receivable, net 954,730 — — 980,317 980,317 Accrued interest receivable 3,140 19 246 2,875 3,140 Financial Liabilities: Deposit $ 995,993 $ — $ 997,256 $ — $ 997,256 Accrued interest payable 2,541 — 2,541 — 2,541 The carrying amounts and estimated fair values of financial instruments not carried at fair value at December 31, 2018 are as follows: Carrying Amount Level 1 Level 2 Level 3 Value As of December 31, 2018: (Dollars in thousands) Financial Assets: Cash and cash equivalents $ 77,726 $ 77,726 $ — $ — $ 77,726 Loans held for sale 752 — 806 — 806 Loans receivable, net 865,423 — — 862,394 862,394 Accrued interest receivable 3,068 44 240 2,784 3,068 Financial Liabilities: Deposit $ 905,176 $ — $ 904,466 $ — $ 904,466 Accrued interest payable 1,715 — 1,715 — 1,715 |
Regulatory Capital Matters
Regulatory Capital Matters | 9 Months Ended |
Sep. 30, 2019 | |
Regulatory Capital Requirements [Abstract] | |
Regulatory Capital Matters | Note 16. Regulatory Capital Matters Banks and bank holding companies are subject to regulatory capital requirements administered by federal banking agencies. Capital adequacy guidelines and, additionally for banks, prompt corrective action regulations involve quantitative measures of assets, liabilities, and certain off-balance-sheet items calculated under regulatory accounting practices. Capital amounts and classifications are also subject to qualitative judgments by regulators. Failure to meet capital requirements can initiate regulatory action. Under the Basel III rules, the Bank must hold a capital conservation buffer above the adequately capitalized risk-based capital ratios. The capital conservation buffer was 0.625% in 2016 and increased 0.625% annually until 2019. As of Prompt corrective action regulations provide five classifications: well capitalized, adequately capitalized, undercapitalized, significantly undercapitalized, and critically undercapitalized, although these terms are not used to represent overall financial condition. If adequately capitalized, regulatory approval is required to accept brokered deposits. If undercapitalized, capital distributions are limited, as is asset growth and expansion, and capital restoration plans are required. At September 30, 2019 and December 31, 2018, the most recent regulatory notifications categorized the Bank as well capitalized under the regulatory framework for prompt corrective action. There are no conditions or events since that notification that management believes have changed the institution’s category. Actual and required capital amounts (in thousands) and ratios, exclusive of the capital conservation buffer, are presented below as of September 30, 2019 and December 31, 2018: Required for Minimum Capital Adequacy To be Considered Actual Purposes "Well Capitalized" (Dollars in thousands) Amount Ratio Amount Ratio Amount Ratio As of September 30, 2019: Total capital (to risk-weighted assets) Consolidated $ 146,641 15.36 % N/A N/A N/A N/A Bank 143,407 15.03 % 76,332 8.00 % 95,415 10.00 % Tier 1 capital (to risk-weighted assets) Consolidated 136,922 14.35 % N/A N/A N/A N/A Bank 133,688 14.01 % 57,249 6.00 % 76,332 8.00 % Common equity Tier 1 capital (to risk-weighted assets) Consolidated 136,922 14.35 % N/A N/A N/A N/A Bank 133,688 14.01 % 42,937 4.50 % 62,020 6.50 % Tier 1 capital (to average assets) Consolidated 136,922 12.11 % N/A N/A N/A N/A Bank 133,688 11.83 % 45,212 4.00 % 56,515 5.00 % Required for Minimum Capital Adequacy To be Considered Actual Purposes "Well Capitalized" (Dollars in thousands) Amount Ratio Amount Ratio Amount Ratio As of December 31, 2018: Total capital (to risk-weighted assets) Consolidated $ 139,593 16.26 % N/A N/A N/A N/A Bank 139,538 16.25 % 68,686 8.00 % 85,857 10.00 % Tier 1 capital (to risk-weighted assets) Consolidated 129,893 15.13 % N/A N/A N/A N/A Bank 129,838 15.12 % 51,514 6.00 % 68,686 8.00 % Common equity Tier 1 capital (to risk-weighted assets) Consolidated 129,893 15.13 % N/A N/A N/A N/A Bank 129,838 15.12 % 38,636 4.50 % 55,807 6.50 % Tier 1 capital (to average assets) Consolidated 129,893 12.88 % N/A N/A N/A N/A Bank 129,838 12.87 % 40,346 4.00 % 50,432 5.00 % |
Earnings Per Share
Earnings Per Share | 9 Months Ended |
Sep. 30, 2019 | |
Earnings Per Share [Abstract] | |
Earnings Per Share | Note 17. Earnings per Share The two-class method is used in the calculation of basic and diluted earnings per share. Under the two-class method, earnings available to common shares are allocated between common shares and participating securities. The Company’s restricted stock awards are considered participating securities as the unvested awards have non-forfeitable rights to dividends, paid or unpaid, on unvested awards. The factors used in the earnings per share computation follow: Three Months Ended September 30, (Dollars in thousands, except share data) 2019 2018 Basic Net income $ 4,000 $ 3,481 Undistributed earnings allocated to participating securities (81 ) (107 ) Net income allocated to common shares 3,919 3,374 Weighted average common shares outstanding 15,768,654 15,714,226 Basic earnings per common share $ 0.25 $ 0.22 Diluted Net income allocated to common shares $ 3,918 $ 3,375 Weighted average common shares outstanding for basic earnings per common share 15,768,654 15,714,226 Add: Dilutive effects of assumed exercises of stock options 238,832 520,700 Average shares and dilutive potential common shares 16,007,486 16,234,926 Diluted earnings per common share $ 0.24 $ 0.21 Nine Months Ended September 30, (Dollars in thousands, except share data) 2019 2018 Basic Net income $ 12,576 $ 10,489 Undistributed earnings allocated to participating securities (309 ) (320 ) Net income allocated to common shares 12,267 10,169 Weighted average common shares outstanding 15,756,886 14,870,232 Basic earnings per common share $ 0.78 $ 0.68 Diluted Net income allocated to common shares $ 12,267 $ 10,169 Weighted average common shares outstanding for basic earnings per common share 15,756,886 14,870,232 Add: Dilutive effects of assumed exercises of stock options 235,129 506,750 Average shares and dilutive potential common shares 15,992,015 15,376,982 Diluted earnings per common share $ 0.77 $ 0.66 No shares of common stock were antidilutive for the three and nine months ended September 30, 2019, and for the three months and nine months ended September 30, 2018. |
Summary of Significant Accoun_2
Summary of Significant Accounting Policies (Policies) | 9 Months Ended |
Sep. 30, 2019 | |
Accounting Policies [Abstract] | |
Basis of Presentation | Basis of Presentation: The accompanying unaudited consolidated financial statements and notes thereto of the Company have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (“SEC”) for Form 10-Q and conform to practices within the banking industry and include all of the information and disclosures required by accounting principles generally accepted in the United States of America (“GAAP”) for interim financial reporting. The accompanying unaudited consolidated financial statements reflect all adjustments (consisting only of normal recurring adjustments), which are necessary for a fair presentation of financial results for the interim periods presented, including eliminating intercompany transactions and balances. The results of operations for the interim periods are not necessarily indicative of the results for the full year. These interim unaudited financial statements should be read in conjunction with the audited consolidated financial statements and the notes thereto as of and for the year ended December 31, 2018, included in the Companys’ Annual Report on Form 10-K for the year ended December 31, 2018. |
Use of Estimates | Use of Estimates: To prepare financial statements in conformity with GAAP, management makes estimates and assumptions based on available information. These estimates and assumptions affect the amounts reported in the financial statements and the disclosures provided, and actual results could differ. |
Concentration of Risk | Concentration of Risk: Most of the Company’s customers are located within Los Angeles County and the surrounding area. The concentration of loans originated in this area may subject the Company to the risk of adverse impacts of economic, regulatory or other developments that could occur in Southern California. The Company has significant concentration in commercial real estate loans. The Company obtains what it believes to be sufficient collateral to secure potential losses. The extent and value of the collateral obtained varies based upon the details underlying each loan agreement. |
Reclassifications | Reclassifications: Some items in the prior period financial statements were reclassified to conform to the current presentation. Reclassification had no effect on prior year net income or shareholders’ equity. There has been no significant or material changes to the Company’s accounting policies during the three months ended September 30, 2019, as compared to the Summary of Significant Accounting Policies as described in “Note 2 of the Notes to Consolidated Financial Statements” in the Company’s unaudited consolidated financial statements included in its Quarterly Report on Form 10-Q for the period ended June 30, 2019. |
Recent Accounting Pronouncements | Recent Accounting Pronouncements: In June 2016, the FASB issued ASU 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (ASU 2016-13). The objective of ASU 2016-13 is to provide financial statement users with decision-useful information about the expected credit losses on financial instruments and other commitments to extend credit. ASU 2016-13 includes provisions that require financial assets measured at amortized cost (such as loans and held to maturity (HTM) debt securities) to be presented at the net amount expected to be collected. This will be accomplished through recognition of an estimate of all current expected credit losses. The estimate will include forecasted information for the timeframe that an entity is able to develop reasonable and supportable forecasts. This is a change from the current practice of recognizing incurred losses based on the probable initial recognition threshold under current GAAP. In addition, credit losses on available for sale (AFS) debt securities will be recorded through an allowance for credit losses rather than as a write-down. Under ASU 2016-13, an entity will be able to record reversals of credit losses in current period income when the estimate of credit losses declines, whereas current GAAP prohibits reflecting those improvements in current period earnings. ASU 2016-13 is effective for annual periods and interim periods within those annual periods beginning after December 15, 2019, initially, and early adoption is permitted for fiscal years, including interim periods, beginning after December 15, 2018. ASU 2016-13 will be applied through a cumulative effect adjustment to retained earnings (modified-retrospective approach), except for debt securities for which an other-than-temporary impairment had been recognized before the effective date. A prospective transition approach is required for these debt securities. The Company is currently evaluating the effects of ASU 2016-13 on its financial statements and disclosures, including software solutions, data requirements and loss estimation methodologies. The company has engaged a third party advisor to develop a new expected loss model. While the effects cannot yet be quantified, the Company expects ASU 2016-13 to add complexity and costs to its current credit loss evaluation process. On July 2019, FASB proposed the effective date delay to January 2020 for SEC filers, excluding smalller reporting companies (SRCs), and January 2023 for all other entities including SRCs, and on October 2019, FASB voted to approve the proposed delay. The Board will draft a final ASU for vote by written ballot. The Compnay expects the adoption date would be January 2023. In August 2018, the FASB issued ASU 2018-13, “Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement”. ASU 2018-13 adds, modifies, and removes disclosure requirements for fair value measurements. ASU 2018-13 is effective annual periods in fiscal years beginning after December 15, 2019, including interim periods within those annual periods. Early adoption is permitted upon the issuance of ASU 2018-13. The Company does not expect this ASU to have a material impact on its financial statements and disclosures. In February 2016, the FASB issued its new lease accounting guidance in ASU No. 2016-02, Leases (Topic 842) Codification Improvements to Topic 842, Leases Leases (Topic 842): Targeted Improvements In March 2017, the FASB issued ASU 2017-08, Receivables—Nonrefundable Fees and Other Costs (Subtopic 310-20) (ASU 2017-08). ASU 2017-08 amends the amortization period for certain purchased callable debt securities held at a premium. Prior to the issuance of this guidance, premiums were amortized as an adjustment of yield over the contractual life of the instrument. ASU 2017-08 requires premiums on purchased callable debt securities that have explicit, noncontingent call features that are callable at fixed prices to be amortized to the earliest call date. There are no accounting changes for securities held at a discount. This ASU is effective for annual periods and interim periods within those annual periods beginning after December 15, 2018, and early adoption is permitted. ASU 2017-08 will be applied through a cumulative effect adjustment through equity (modified-retrospective approach). The Company did not have callable debt securities held at a premium at December 31, 2018 or September 30, 2019. |
Securities (Tables)
Securities (Tables) | 9 Months Ended |
Sep. 30, 2019 | |
Investments Debt And Equity Securities [Abstract] | |
Schedule of Amortized Cost, Fair Value, and the Corresponding Amounts of Gross Unrealized Gains and Losses | The following table summarizes the amortized cost, fair value, and the corresponding amounts of gross unrealized gains and losses for available for sale securities as of September 30, 2019 and December 31, 2018: Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value As of September 30, 2019: (Dollars in thousands) Available for sale: U.S. Government sponsored agency securities $ 5,998 $ — $ (6 ) $ 5,992 Mortgage-backed securities: residential 12,160 61 (24 ) 12,197 Collateralized mortgage obligations: residential 33,757 395 (46 ) 34,106 Total available for sale $ 51,915 $ 456 $ (76 ) $ 52,295 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value As of December 31, 2018: (Dollars in thousands) Available for sale: U.S. Government sponsored agency securities $ 6,994 $ — $ (88 ) $ 6,906 Mortgage-backed securities: residential 14,465 — (336 ) 14,129 Collateralized mortgage obligations: residential 34,655 156 (510 ) 34,301 Total available for sale $ 56,114 $ 156 $ (934 ) $ 55,336 |
Schedule of Amortized Cost and Estimated Fair Value of Securities Available for Sale | There were no sales of securities available for sale in the three or nine months ended September 30, 2019 or 2018. The amortized cost and estimated fair value of securities available for sale at September 30, 2019, by contractual maturity, are shown below. Securities without a contractual maturity are shown separately. Amortized Cost Fair Value As of September 30, 2019: (Dollars in thousands) Available for sale: Within one year $ 3,998 $ 3,995 One to five years 2,000 1,997 Mortgage-backed securities: residential 12,160 12,197 Collateralized mortgage obligations 33,757 34,106 Total available for sale $ 51,915 $ 52,295 |
Schedule of Securities With Unrealized Losses | The following table summarizes securities with unrealized losses as of September 30, 2019 and December 31, 2018, aggregated by length of time in a continuous unrealized loss position: Less Than 12 Months 12 Months or Longer Total Fair Value Unrealized Losses Fair Value Unrealized Losses Fair Value Unrealized Losses As of September 30, 2019: (Dollars in thousands) Available for sale: U.S. Government sponsored agency securities $ 1,000 $ — $ 3,992 $ (6 ) $ 4,992 $ (6 ) Mortgage-backed securities: residential 1,176 — 3,442 (24 ) 4,618 (24 ) Collateralized mortgage obligations 2,140 (14 ) 4,014 (32 ) 6,154 (46 ) Total available for sale $ 4,316 $ (14 ) $ 11,448 $ (62 ) $ 15,764 $ (76 ) Less Than 12 Months 12 Months or Longer Total Fair Value Unrealized Losses Fair Value Unrealized Losses Fair Value Unrealized Losses As of December 31, 2018: (Dollars in thousands) Available for sale: U.S. Government sponsored agency securities $ — $ — $ 6,906 $ (88 ) $ 6,906 $ (88 ) Mortgage-backed securities: residential 3,209 (23 ) 10,920 (313 ) 14,129 (336 ) Collateralized mortgage obligations 3,348 (26 ) 14,544 (484 ) 17,892 (510 ) Total available for sale $ 6,557 $ (49 ) $ 32,370 $ (885 ) $ 38,927 $ (934 ) |
Schedule of Other Investments | Other investments as of September 30, 2019 and December 31, 2018, consisted of the following: September 30, 2019 December 31, 2018 (Dollars in thousands) FHLB stock $ 5,358 $ 4,582 PCBB stock 190 190 Mutual fund - CRA qualified 3,625 2,488 Total other investments $ 9,173 $ 7,260 |
Loans (Tables)
Loans (Tables) | 9 Months Ended |
Sep. 30, 2019 | |
Receivables [Abstract] | |
Composition of Loan Portfolio | The composition of the loan portfolio was as follows at September 30, 2019 and December 31, 2018: September 30, 2019 December 31, 2018 (Dollars in thousands) Real estate: Commercial real estate $ 594,447 $ 503,834 SBA loans—real estate 124,963 117,834 Total real estate 719,410 621,668 SBA loans—non-real estate 11,269 9,541 Commercial and industrial 107,730 113,975 Home mortgage 123,092 127,298 Consumer 2,869 2,577 Gross loans receivable 964,370 875,059 Allowance for loan losses (9,640 ) (9,636 ) Loans receivable, net $ 954,730 $ 865,423 |
Schedule of Activity in Allowance for Loan Losses | The activity in the allowance for loan losses for the three and nine months ended September 30, 2019 and 2018 was as follows: SBA Commercial SBA Loans Loans Non- Commercial Home Real Estate Real Estate Real Estate and Industrial Mortgage Consumer Total (Dollars in thousands) Three months ended September 30, 2019: Beginning balance $ 5,554 $ 933 $ 119 $ 1,266 $ 1,609 $ 44 $ 9,525 Provision for loan losses 102 — (2 ) 171 26 (7 ) 290 Charge-offs — — — (175 ) — — (175 ) Recoveries — — — — — — — Ending balance $ 5,656 $ 933 $ 117 $ 1,262 $ 1,635 $ 37 $ 9,640 Three months ended September 30, 2018: Beginning balance $ 4,804 $ 978 $ 536 $ 1,877 $ 1,489 $ 39 $ 9,723 Provision for loan losses 271 30 89 43 12 (6 ) 439 Charge-offs — — (57 ) (565 ) — — (622 ) Recoveries — — 6 5 — — 11 Ending balance $ 5,075 $ 1,008 $ 574 $ 1,360 $ 1,501 $ 33 $ 9,551 SBA Commercial SBA Loans Loans Non- Commercial Home Real Estate Real Estate Real Estate and Industrial Mortgage Consumer Total (Dollars in thousands) Nine months ended September 30, 2019: Beginning balance $ 4,805 $ 894 $ 505 $ 1,746 $ 1,653 $ 33 $ 9,636 Provision for loan losses 851 59 (388 ) 184 (18 ) 3 691 Charge-offs — (20 ) — (668 ) — — (688 ) Recoveries — — — — — 1 1 Ending balance $ 5,656 $ 933 $ 117 $ 1,262 $ 1,635 $ 37 $ 9,640 Nine months ended September 30, 2018: Beginning balance $ 4,801 $ 1,082 $ 538 $ 1,265 $ 1,408 $ 45 $ 9,139 Provision for loan losses 274 (74 ) 112 654 93 (12 ) 1,047 Charge-offs — — (85 ) (565 ) — — (650 ) Recoveries — — 9 6 — — 15 Ending balance $ 5,075 $ 1,008 $ 574 $ 1,360 $ 1,501 $ 33 $ 9,551 |
Schedule of Allowance for Loan Losses and Recorded Investment in Loans by Portfolio Segment | The following table presents the balance in the allowance for loan losses and the recorded investment in loans by portfolio segment as of September 30, 2019 and December 31, 2018: Loans Individually Evaluated for Impairment Loans Collectively Evaluated for Impairment Total As of September 30, 2019: (Dollars in thousands) Allowance for loan losses: Commercial real estate $ — $ 5,656 $ 5,656 SBA loans—real estate — 933 933 SBA loans—non-real estate — 117 117 Commercial and industrial 336 926 1,262 Home mortgage — 1,635 1,635 Consumer — 37 37 Total $ 336 $ 9,304 $ 9,640 Loans: Commercial real estate $ — $ 595,903 $ 595,903 SBA loans—real estate 488 125,085 125,573 SBA loans—non-real estate 36 11,295 11,331 Commercial and industrial 336 107,646 107,982 Home mortgage — 123,581 123,581 Consumer — 2,875 2,875 Total $ 860 $ 966,385 $ 967,245 As of December 31, 2018: Allowance for loan losses: Commercial real estate $ — $ 4,805 $ 4,805 SBA loans—real estate — 894 894 SBA loans—non-real estate 362 143 505 Commercial and industrial 836 910 1,746 Home mortgage — 1,653 1,653 Consumer — 33 33 Total $ 1,198 $ 8,438 $ 9,636 Loans: Commercial real estate $ — $ 505,229 $ 505,229 SBA loans—real estate 834 117,159 117,993 SBA loans—non-real estate 57 9,875 9,932 Commercial and industrial 1,516 112,781 114,297 Home mortgage — 127,806 127,806 Consumer — 2,586 2,586 Total $ 2,407 $ 875,436 $ 877,843 |
Schedule of Information Related to Impaired Loans by Class of Loans | The following table presents information related to impaired loans by class of loans as of and for the three and nine months ended September 30, 2019 and 2018. The difference between the unpaid principal balance (net of partial charge-offs) and the recorded investment in the loans is not considered to be material. The difference between interest income recognized and cash basis interest recognized was immaterial. Average Interest Recorded Allowance Recorded Income Investment Allocated Investment Recognized As of and for the three months ended September 30, 2019: (Dollars in thousands) With no related allowance recorded: SBA loans—real estate $ 488 $ — $ 493 $ — SBA loans—non-real estate 36 — 28 — With an allowance recorded: Commercial and industrial 336 336 337 5 Total $ 860 $ 336 $ 858 $ 5 As of and for the three months ended September 30, 2018: With no related allowance recorded: SBA loans—real estate $ 134 $ — $ 138 $ — Commercial and industrial 748 — 749 11 With an allowance recorded: SBA loans—non-real estate 434 434 434 — Commercial and industrial 345 345 348 5 Total $ 1,661 $ 779 $ 1,669 $ 16 Average Interest Recorded Allowance Recorded Income Investment Allocated Investment Recognized As of and for the nine months ended September 30, 2019: (Dollars in thousands) With no related allowance recorded: SBA loans—real estate $ 488 $ — $ 505 $ — SBA loans—non-real estate 36 — 46 — With an allowance recorded: Commercial and industrial 336 336 339 15 Total $ 860 $ 336 $ 890 $ 15 As of and for the nine months ended September 30, 2018: With no related allowance recorded: Home mortgage $ 134 $ — $ 137 $ — Consumer 748 — 749 33 With an allowance recorded: SBA loans—non-real estate 434 434 443 — Commercial and industrial 345 345 350 14 Total $ 1,661 $ 779 $ 1,679 $ 47 |
Schedule of Recorded Investment in Nonaccrual Loans and Loans Past Due Greater Than 90 Days Still Accruing Interest by Class of Loans | The following table presents the recorded investment in nonaccrual loans and loans past due greater than 90 days still accruing interest, by class of loans, as of September 30, 2019 and December 31, 2018: Nonaccrual Loans >90 Days Past Due & Still Accruing Total As of September 30, 2019: (Dollars in thousands) SBA loans—real estate $ 488 $ — $ 488 SBA loans—non-real estate 36 — 36 Commercial and industrial 710 — 710 Total $ 1,234 $ — $ 1,234 As of December 31, 2018: SBA loans—real estate $ 834 $ — $ 834 SBA loans—non-real estate 57 — 57 Commercial and industrial 680 — 680 Total $ 1,571 $ — $ 1,571 |
Schedule of Aging of Recorded Investment in Past Due Loans | The following table represents the aging of the recorded investment in past due loans as of September 30, 2019 and December 31, 2018: 30-59 Days Past Due 60-89 Days Past Due > 90 Days Past Due Total Past Due Loans Not Past Due Total As of September 30, 2019: (Dollars in thousands) Commercial real estate $ 472 $ — $ — $ 472 $ 595,431 $ 595,903 SBA—real estate 1,293 580 — 1,873 123,700 125,573 SBA—non-real estate 3 — — 3 11,328 11,331 Commercial and industrial 374 — — 374 107,608 107,982 Home mortgage 437 — 710 1,147 122,434 123,581 Consumer — — — — 2,875 2,875 $ 2,579 $ 580 $ 710 $ 3,869 $ 963,376 $ 967,245 As of December 31, 2018: Commercial real estate $ — $ — $ — $ — $ 505,229 $ 505,229 SBA—real estate — — 311 311 117,682 117,993 SBA—non-real estate — — — — 9,932 9,932 Commercial and industrial — — 680 680 113,617 114,297 Home mortgage 449 — — 449 127,357 127,806 Consumer — — — — 2,586 2,586 $ 449 $ — $ 991 $ 1,440 $ 876,403 $ 877,843 |
Schedule of Risk Category of Loans by Class of Loans | As of September 30, 2019 and December 31, 2018, and based on the most recent analysis performed, the risk category of loans by class of loans is as follows: Pass Special Mention Substandard Doubtful Total As of September 30, 2019: (Dollars in thousands) Commercial real estate $ 595,903 $ — $ — $ — $ 595,903 SBA loans—real estate 122,553 773 2,247 — 125,573 SBA loans—non-real estate 11,281 14 36 — 11,331 Commercial and industrial 106,379 893 710 — 107,982 Home mortgage 123,325 — 256 — 123,581 Consumer 2,875 — — — 2,875 $ 962,316 $ 1,680 $ 3,249 $ — $ 967,245 As of December 31, 2018: Commercial real estate $ 505,229 $ — $ — $ — $ 505,229 SBA loans—real estate 115,993 — 2,000 — 117,993 SBA loans—non-real estate 9,859 16 57 — 9,932 Commercial and industrial 112,781 — 1,516 — 114,297 Home mortgage 127,806 — — — 127,806 Consumer 2,586 — — — 2,586 $ 874,254 $ 16 $ 3,573 $ — $ 877,843 |
Leases (Tables)
Leases (Tables) | 9 Months Ended |
Sep. 30, 2019 | |
Leases [Abstract] | |
Summary of Lease, Cost | The table below summarized the Company’s total lease cost: Three Months Ended Nine Months Ended (Dollars in thousands) September 30, 2019 September 30, 2019 Operating lease cost $ 444 $ 1,287 Variable lease cost 211 548 Total lease cost $ 655 $ 1,835 |
Summary of Other Information Related to Operating Leases | The table below summarizes other information related to the Company’s operating leases: Three Months Ended Nine Months Ended (Dollars in thousands) September 30, 2019 September 30, 2019 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 493 $ 1,408 Weighted average remaining lease term - operating leases 6.0 years Weighted average discount rate - operating leases 2.98 % |
Summary of Remaining Contractually Obligated Lease Payments and Reconciliation to Lease liability | The table below summarizes the remaining contractually obligated lease payments and a reconciliation to the lease liability reported on the consolidated balance sheet as of September 30, 2019: (Dollars in thousands) September 30, 2019 2019 remaining $ 301 2020 2,002 2021 2,032 2022 2,028 2023 1,816 Thereafter 3,343 Total lease payments 11,522 Discount to present value (1,187 ) Total lease liability $ 10,335 |
Summary of Rent Commitments Related to Lease | Rent commitments related to the lease of the Company’s main office and branch facilities, before considering renewal options and additional lessor charges as of December 31, 2018, were as follows: (Dollars in thousands) December 31, 2018 2019 $ 1,709 2020 1,757 2021 1,742 2022 1,685 2023 1,455 Thereafter 2,669 Total $ 11,017 |
Premises and Equipment (Tables)
Premises and Equipment (Tables) | 9 Months Ended |
Sep. 30, 2019 | |
Property Plant And Equipment [Abstract] | |
Schedule of Premises and Equipment | The Company’s premises and equipment consisted of the following as of September 30, 2019 and December 31, 2018: September 30, 2019 December 31, 2018 (Dollars in thousands) Leasehold improvements $ 6,505 $ 5,518 Furniture and fixtures 3,155 2,791 Equipment and others 2,329 2,111 Total cost 11,989 10,420 Accumulated depreciation (6,622 ) (5,787 ) Net book value $ 5,367 $ 4,633 |
Servicing Assets (Tables)
Servicing Assets (Tables) | 9 Months Ended |
Sep. 30, 2019 | |
Servicing Asset [Abstract] | |
Schedule of Activity for Loan Servicing Assets | Activity for loan servicing assets during the three and nine months ended September 30, 2019 and 2018 is as follows: Three Months Ended September 30, Nine Months Ended September 30, 2019 2018 2019 2018 (Dollars in thousands) Beginning balance $ 6,996 $ 6,994 $ 6,987 $ 6,771 Additions 552 588 1,553 1,621 Amortized to expense (589 ) (485 ) (1,581 ) (1,295 ) Ending balance $ 6,959 $ 7,097 $ 6,959 $ 7,097 |
Deposits (Tables)
Deposits (Tables) | 9 Months Ended |
Sep. 30, 2019 | |
Banking And Thrift [Abstract] | |
Schedule of Maturities of Time Deposits | The scheduled maturities of time deposits were as follows as of September 30, 2019: September 30, 2019 (Dollars in thousands) 2019 remaining $ 124,973 2020 288,900 2021 5,458 2022 972 2023 724 Thereafter 121 Total $ 421,148 |
Borrowing Arrangements (Tables)
Borrowing Arrangements (Tables) | 9 Months Ended |
Sep. 30, 2019 | |
Debt Disclosure [Abstract] | |
Summary of Borrowings Available to the Company from Institutions | The Company had available borrowings from the following institutions as of September 30, 2019: September 30, 2019 (Dollars in thousands) Federal Home Loan Bank—San Francisco $ 232,865 Federal Reserve Bank 120,289 Pacific Coast Bankers Bank 8,000 Zions Bank 5,500 Total $ 366,654 |
Commitments and Contingencies (
Commitments and Contingencies (Tables) | 9 Months Ended |
Sep. 30, 2019 | |
Commitments And Contingencies Disclosure [Abstract] | |
Summary of Distribution of Undisbursed Loan Commitments | The following table shows the distribution of undisbursed loan commitments as of the dates indicated: September 30, 2019 December 31, 2018 (Dollars in thousands) Commitments to extend credit $ 76,094 $ 60,789 Standby letter of credit 3,983 1,790 Commercial letter of credit 973 1,209 Total undisbursed loan commitments $ 81,050 $ 63,788 |
Stock-based Compensation (Table
Stock-based Compensation (Tables) | 9 Months Ended |
Sep. 30, 2019 | |
2005 Plan | |
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |
Summary of Stock-based Compensation Stock Options Activity | A summary of the transactions under the 2005 Plan for the nine months ended September 30, 2019 is as follows: Weighted Number of Average Aggregate Options Exercise Intrinsic Outstanding Price Value (Dollars in thousands, except per share data) Outstanding, as of January 1, 2019 250,000 $ 4.00 Options granted — — Options exercised (95,000 ) 2.20 Options forfeited — — Options expired — — Outstanding, as of September 30, 2019 155,000 4.70 $ 787 Fully vested and expected to vest 155,000 4.70 $ 787 Vested 155,000 $ 4.70 $ 787 |
Summary of Information Related to Stock Option Plan | Information related to the 2005 Plan for the periods indicated follows: Three Months Ended September 30, Nine Months Ended September 30, 2019 2018 2019 2018 (Dollars in thousands) Intrinsic value of options exercised $ 206 $ 234 $ 593 $ 487 Cash received from option exercises 72 119 179 195 Tax benefit realized from option exercised 5 — 5 — |
2010 Plan | |
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |
Summary of Stock-based Compensation Stock Options Activity | A summary of stock options outstanding under the 2010 Plan for the nine months ended September 30, 2019 is as follows: Weighted Number of Average Aggregate Options Exercise Intrinsic Outstanding Price Value (Dollars in thousands, except per share data) Outstanding, as of January 1, 2019 620,000 $ 4.57 Options granted — — Options exercised (165,000 ) 1.12 Options forfeited — — Options expired — — Outstanding, as of September 30, 2019 455,000 5.20 $ 2,085 Fully vested and expected to vest 440,000 5.10 $ 2,058 Vested 395,000 $ 4.77 $ 1,978 |
Summary of Information Related to Stock Option Plan | Information related to stock options exercised under the 2010 Plan for the periods indicated follows: Three Months Ended September 30, Nine Months Ended September 30, 2019 2018 2019 2018 (Dollars in thousands) Intrinsic value of options exercised $ — $ — $ 1,090 $ 876 Cash received from option exercises — — 185 319 Tax benefit realized from option exercised — — 285 160 |
Summary of Changes in Non-vested Restricted Stock Awards | A summary of the changes in the Company’s non-vested restricted stock awards under the 2010 Plan for the nine months ended September 30, 2019 is as follows: Shares Issued Weighted Average Grant Date Fair Value Aggregate Intrinsic Value (Dollars in thousands, except share data) Non-vested, as of January 1, 2019 436,000 $ 8.19 Awards granted 3,000 8.15 Awards vested (141,500 ) 5.91 Awards forfeited (8,000 ) 10.10 Non-vested, as of September 30, 2019 289,500 $ 9.25 $ 2,831 |
2010 Plan | Restricted Stock Awards | |
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |
Summary of Information Related to Non-vested Restricted Stock Awards | Information related to non-vested restricted stock awards under the 2010 Plan for the periods indicated follows: Three Months Ended September 30, Nine Months Ended September 30, 2019 2018 2019 2018 (Dollars in thousands) Tax benefit realized from awards vested $ 141 $ 272 $ 144 $ 285 |
Fair Value of Financial Instr_2
Fair Value of Financial Instruments (Tables) | 9 Months Ended |
Sep. 30, 2019 | |
Fair Value Disclosures [Abstract] | |
Summary of Assets and Liabilities Measured at Fair Value on Recurring Basis | Assets and liabilities measured at fair value on a recurring basis as of September 30, 2019 and December 31, 2018 are summarized below: Fair Value Measuring Using Quoted Significant Other Significant Prices in Observable Unobservable Total Active Markets Inputs Inputs Fair Value (Level 1) (Level 2) (Level 3) (Dollars in thousands) As of September 30, 2019 : U.S. Government sponsored agency securities $ 5,992 $ — $ 5,992 $ — Mortgage-backed securities - residential 12,197 — 12,197 — Collateralized mortgage obligations 34,106 — 34,106 — Other investments: Mutual fund - CRA qualified 3,625 3,625 — — As of December 31, 2018 : U.S. Government sponsored agency securities $ 6,906 $ — $ 6,906 $ — Mortgage-backed securities - residential 14,129 — 14,129 — Collateralized mortgage obligations 34,301 — 34,301 — Other investments: Mutual fund - CRA qualified 2,488 2,488 — — |
Summary of Carrying Amounts and Estimated Fair Values of Financial Instruments Not Carried at Fair Value | Financial Instruments Carrying Amount Level 1 Level 2 Level 3 Value As of September 30, 2019: (Dollars in thousands) Financial Assets: Cash and cash equivalents $ 89,107 $ 89,107 $ — $ — $ 89,107 Loans held for sale 368 — 397 — 397 Loans receivable, net 954,730 — — 980,317 980,317 Accrued interest receivable 3,140 19 246 2,875 3,140 Financial Liabilities: Deposit $ 995,993 $ — $ 997,256 $ — $ 997,256 Accrued interest payable 2,541 — 2,541 — 2,541 The carrying amounts and estimated fair values of financial instruments not carried at fair value at December 31, 2018 are as follows: Carrying Amount Level 1 Level 2 Level 3 Value As of December 31, 2018: (Dollars in thousands) Financial Assets: Cash and cash equivalents $ 77,726 $ 77,726 $ — $ — $ 77,726 Loans held for sale 752 — 806 — 806 Loans receivable, net 865,423 — — 862,394 862,394 Accrued interest receivable 3,068 44 240 2,784 3,068 Financial Liabilities: Deposit $ 905,176 $ — $ 904,466 $ — $ 904,466 Accrued interest payable 1,715 — 1,715 — 1,715 |
Regulatory Capital Matters (Tab
Regulatory Capital Matters (Tables) | 9 Months Ended |
Sep. 30, 2019 | |
Regulatory Capital Requirements [Abstract] | |
Summary of Actual and Required Capital Amounts and Ratios, Exclusive of Capital Conservation Buffer | Actual and required capital amounts (in thousands) and ratios, exclusive of the capital conservation buffer, are presented below as of September 30, 2019 and December 31, 2018: Required for Minimum Capital Adequacy To be Considered Actual Purposes "Well Capitalized" (Dollars in thousands) Amount Ratio Amount Ratio Amount Ratio As of September 30, 2019: Total capital (to risk-weighted assets) Consolidated $ 146,641 15.36 % N/A N/A N/A N/A Bank 143,407 15.03 % 76,332 8.00 % 95,415 10.00 % Tier 1 capital (to risk-weighted assets) Consolidated 136,922 14.35 % N/A N/A N/A N/A Bank 133,688 14.01 % 57,249 6.00 % 76,332 8.00 % Common equity Tier 1 capital (to risk-weighted assets) Consolidated 136,922 14.35 % N/A N/A N/A N/A Bank 133,688 14.01 % 42,937 4.50 % 62,020 6.50 % Tier 1 capital (to average assets) Consolidated 136,922 12.11 % N/A N/A N/A N/A Bank 133,688 11.83 % 45,212 4.00 % 56,515 5.00 % Required for Minimum Capital Adequacy To be Considered Actual Purposes "Well Capitalized" (Dollars in thousands) Amount Ratio Amount Ratio Amount Ratio As of December 31, 2018: Total capital (to risk-weighted assets) Consolidated $ 139,593 16.26 % N/A N/A N/A N/A Bank 139,538 16.25 % 68,686 8.00 % 85,857 10.00 % Tier 1 capital (to risk-weighted assets) Consolidated 129,893 15.13 % N/A N/A N/A N/A Bank 129,838 15.12 % 51,514 6.00 % 68,686 8.00 % Common equity Tier 1 capital (to risk-weighted assets) Consolidated 129,893 15.13 % N/A N/A N/A N/A Bank 129,838 15.12 % 38,636 4.50 % 55,807 6.50 % Tier 1 capital (to average assets) Consolidated 129,893 12.88 % N/A N/A N/A N/A Bank 129,838 12.87 % 40,346 4.00 % 50,432 5.00 % |
Earnings Per Share (Tables)
Earnings Per Share (Tables) | 9 Months Ended |
Sep. 30, 2019 | |
Earnings Per Share [Abstract] | |
Computation of Basic and Diluted Earnings Per Share | The factors used in the earnings per share computation follow: Three Months Ended September 30, (Dollars in thousands, except share data) 2019 2018 Basic Net income $ 4,000 $ 3,481 Undistributed earnings allocated to participating securities (81 ) (107 ) Net income allocated to common shares 3,919 3,374 Weighted average common shares outstanding 15,768,654 15,714,226 Basic earnings per common share $ 0.25 $ 0.22 Diluted Net income allocated to common shares $ 3,918 $ 3,375 Weighted average common shares outstanding for basic earnings per common share 15,768,654 15,714,226 Add: Dilutive effects of assumed exercises of stock options 238,832 520,700 Average shares and dilutive potential common shares 16,007,486 16,234,926 Diluted earnings per common share $ 0.24 $ 0.21 Nine Months Ended September 30, (Dollars in thousands, except share data) 2019 2018 Basic Net income $ 12,576 $ 10,489 Undistributed earnings allocated to participating securities (309 ) (320 ) Net income allocated to common shares 12,267 10,169 Weighted average common shares outstanding 15,756,886 14,870,232 Basic earnings per common share $ 0.78 $ 0.68 Diluted Net income allocated to common shares $ 12,267 $ 10,169 Weighted average common shares outstanding for basic earnings per common share 15,756,886 14,870,232 Add: Dilutive effects of assumed exercises of stock options 235,129 506,750 Average shares and dilutive potential common shares 15,992,015 15,376,982 Diluted earnings per common share $ 0.77 $ 0.66 |
Business Description - Addition
Business Description - Additional Information (Details) | Mar. 27, 2018USD ($)$ / sharesshares | Mar. 31, 2018shares | Sep. 30, 2019BranchOffice |
Business Description [Line Items] | |||
Operations commenced date | Jun. 1, 2016 | ||
Number of full service branches | Branch | 9 | ||
Number of loan production offices | Office | 4 | ||
Common Stock | |||
Business Description [Line Items] | |||
Stock issued under stock offering, net of expenses, shares | shares | 2,300,000 | ||
Proceeds from issuance initial public offering | $ 22,600,000 | ||
Initial Public Offering | Common Stock | |||
Business Description [Line Items] | |||
Stock issued under stock offering, net of expenses, shares | shares | 2,300,000 | ||
Stock price per shre | $ / shares | $ 11 | ||
Payments for underwriting discounts and commissions | $ 1,700,000 | ||
Payments of stock offering expenses | $ 925,000 | ||
Open Bank | |||
Business Description [Line Items] | |||
Percentage of voting equity interests acquired | 100.00% | ||
Operations commenced date | Jun. 10, 2005 |
Summary of Significant Accoun_3
Summary of Significant Accounting Policies - Additional Information (Details) - USD ($) | Jan. 02, 2019 | Sep. 30, 2019 | Jan. 01, 2019 | |
New Accounting Pronouncements Or Change In Accounting Principle [Line Items] | ||||
Operating lease liabilities | [1] | $ 10,335,000 | ||
Operating right-of-use assets | [1] | 8,606,000 | ||
ASU 2016-02 | ||||
New Accounting Pronouncements Or Change In Accounting Principle [Line Items] | ||||
Operating lease liabilities | $ 9,900,000 | |||
Operating right-of-use assets | $ 8,606,000 | $ 8,000,000 | ||
Cumulative-effect adjustment to retained earnings | $ 0 | |||
[1] | The adoption of ASU 2016-02, Leases (Topic 842) in the first quarter of 2019 resulted in the recognition of right-of-use assets and lease liabilities on balance sheet. |
Securities - Schedule of Amorti
Securities - Schedule of Amortized Cost, Fair Value, and the Corresponding Amounts of Gross Unrealized Gains and Losses (Details) - USD ($) $ in Thousands | 9 Months Ended | 12 Months Ended |
Sep. 30, 2019 | Dec. 31, 2018 | |
Schedule Of Available For Sale Securities [Line Items] | ||
Amortized Cost | $ 51,915 | $ 56,114 |
Gross Unrealized Gains | 456 | 156 |
Gross Unrealized Losses | (76) | (934) |
Fair Value | 52,295 | 55,336 |
U.S. Government Sponsored Agency Securities | ||
Schedule Of Available For Sale Securities [Line Items] | ||
Amortized Cost | 5,998 | 6,994 |
Gross Unrealized Losses | (6) | (88) |
Fair Value | 5,992 | 6,906 |
Mortgage-backed Securities, Residential | ||
Schedule Of Available For Sale Securities [Line Items] | ||
Amortized Cost | 12,160 | 14,465 |
Gross Unrealized Gains | 61 | |
Gross Unrealized Losses | (24) | (336) |
Fair Value | 12,197 | 14,129 |
Collateralized Mortgage Obligations, Residential | ||
Schedule Of Available For Sale Securities [Line Items] | ||
Amortized Cost | 33,757 | 34,655 |
Gross Unrealized Gains | 395 | 156 |
Gross Unrealized Losses | (46) | (510) |
Fair Value | $ 34,106 | $ 34,301 |
Securities - Additional Informa
Securities - Additional Information (Details) - USD ($) | 3 Months Ended | 9 Months Ended | 12 Months Ended | ||
Sep. 30, 2019 | Sep. 30, 2018 | Sep. 30, 2019 | Sep. 30, 2018 | Dec. 31, 2018 | |
Schedule Of Available For Sale Securities [Line Items] | |||||
Proceeds from sale of available-for-sale securities | $ 0 | $ 0 | $ 0 | $ 0 | |
Other than temporary impairments unrealized losses on securities | 0 | ||||
Collateral Pledged | |||||
Schedule Of Available For Sale Securities [Line Items] | |||||
Number of securities pledged as collateral | $ 0 | $ 0 | $ 0 | ||
Stockholder's Equity | Credit Concentration Risk | Non-US Government and Agency Securities | |||||
Schedule Of Available For Sale Securities [Line Items] | |||||
Concentration risk, percentage | 10.00% | 10.00% |
Securities - Schedule of Amor_2
Securities - Schedule of Amortized Cost and Estimated Fair Value of Securities Available for Sale (Details) - USD ($) $ in Thousands | Sep. 30, 2019 | Dec. 31, 2018 |
Schedule Of Available For Sale Securities [Line Items] | ||
Within one year, Amortized Cost | $ 3,998 | |
One to five years, Amortized Cost | 2,000 | |
Available for sale, Amortized Cost | 51,915 | $ 56,114 |
Within one year, Fair Value | 3,995 | |
One to five years, Fair Value | 1,997 | |
Available for sale, Fair Value | 52,295 | 55,336 |
Mortgage-backed Securities, Residential | ||
Schedule Of Available For Sale Securities [Line Items] | ||
Available for sale, Amortized Cost | 12,160 | 14,465 |
Available for sale, Fair Value | 12,197 | $ 14,129 |
Collateralized Mortgage Obligations | ||
Schedule Of Available For Sale Securities [Line Items] | ||
Available for sale, Amortized Cost | 33,757 | |
Available for sale, Fair Value | $ 34,106 |
Securities - Schedule of Securi
Securities - Schedule of Securities With Unrealized Losses (Details) - USD ($) $ in Thousands | Sep. 30, 2019 | Dec. 31, 2018 |
Schedule Of Available For Sale Securities [Line Items] | ||
Fair Value, Less Than 12 Months | $ 4,316 | $ 6,557 |
Unrealized Losses, Less Than 12 Months | (14) | (49) |
Fair Value, 12 Months or Longer | 11,448 | 32,370 |
Unrealized Losses, 12 Months or Longer | (62) | (885) |
Total Fair Value | 15,764 | 38,927 |
Total Unrealized Losses | (76) | (934) |
U.S. Government Sponsored Agency Securities | ||
Schedule Of Available For Sale Securities [Line Items] | ||
Fair Value, Less Than 12 Months | 1,000 | |
Fair Value, 12 Months or Longer | 3,992 | 6,906 |
Unrealized Losses, 12 Months or Longer | (6) | (88) |
Total Fair Value | 4,992 | 6,906 |
Total Unrealized Losses | (6) | (88) |
Mortgage-backed Securities, Residential | ||
Schedule Of Available For Sale Securities [Line Items] | ||
Fair Value, Less Than 12 Months | 1,176 | 3,209 |
Unrealized Losses, Less Than 12 Months | (23) | |
Fair Value, 12 Months or Longer | 3,442 | 10,920 |
Unrealized Losses, 12 Months or Longer | (24) | (313) |
Total Fair Value | 4,618 | 14,129 |
Total Unrealized Losses | (24) | (336) |
Collateralized Mortgage Obligations | ||
Schedule Of Available For Sale Securities [Line Items] | ||
Fair Value, Less Than 12 Months | 2,140 | 3,348 |
Unrealized Losses, Less Than 12 Months | (14) | (26) |
Fair Value, 12 Months or Longer | 4,014 | 14,544 |
Unrealized Losses, 12 Months or Longer | (32) | (484) |
Total Fair Value | 6,154 | 17,892 |
Total Unrealized Losses | $ (46) | $ (510) |
Securities - Schedule of Other
Securities - Schedule of Other Investments (Details) - USD ($) $ in Thousands | Sep. 30, 2019 | Dec. 31, 2018 |
Investments Debt And Equity Securities [Abstract] | ||
FHLB stock | $ 5,358 | $ 4,582 |
PCBB stock | 190 | 190 |
Mutual fund - CRA qualified | 3,625 | 2,488 |
Total other investments | $ 9,173 | $ 7,260 |
Loans - Composition of Loan Por
Loans - Composition of Loan Portfolio (Details) - USD ($) $ in Thousands | Sep. 30, 2019 | Dec. 31, 2018 |
Loans And Leases Receivable Disclosure [Line Items] | ||
Gross loans receivable | $ 964,370 | $ 875,059 |
Allowance for loan losses | (9,640) | (9,636) |
Loans receivable, net | 954,730 | 865,423 |
Real Estate | ||
Loans And Leases Receivable Disclosure [Line Items] | ||
Gross loans receivable | 719,410 | 621,668 |
Real Estate | Commercial Real Estate | ||
Loans And Leases Receivable Disclosure [Line Items] | ||
Gross loans receivable | 594,447 | 503,834 |
Real Estate | SBA Loans—Real Estate | ||
Loans And Leases Receivable Disclosure [Line Items] | ||
Gross loans receivable | 124,963 | 117,834 |
SBA Loans—Non-Real Estate | ||
Loans And Leases Receivable Disclosure [Line Items] | ||
Gross loans receivable | 11,269 | 9,541 |
Commercial and Industrial | ||
Loans And Leases Receivable Disclosure [Line Items] | ||
Gross loans receivable | 107,730 | 113,975 |
Home Mortgage | ||
Loans And Leases Receivable Disclosure [Line Items] | ||
Gross loans receivable | 123,092 | 127,298 |
Consumer | ||
Loans And Leases Receivable Disclosure [Line Items] | ||
Gross loans receivable | $ 2,869 | $ 2,577 |
Loans - Additional Information
Loans - Additional Information (Details) | 3 Months Ended | 9 Months Ended | |||
Sep. 30, 2019USD ($)Contract | Sep. 30, 2018USD ($)Contract | Sep. 30, 2019USD ($)Contract | Sep. 30, 2018USD ($)Contract | Dec. 31, 2018USD ($) | |
Accounts Notes Loans And Financing Receivable Gross Allowance And Net [Abstract] | |||||
Loans | $ 0 | $ 0 | $ 0 | ||
Recorded investment in troubled debt restructurings | 336,000 | 336,000 | 343,000 | ||
Specific reserves to customers whose loan terms have been modified in troubled debt restructurings | $ 336,000 | $ 336,000 | $ 343,000 | ||
Loans identified as trouble debt restructurings | Contract | 0 | 0 | 0 | 0 | |
Financing receivable, modifications, subsequent default, recorded investment | $ 0 | $ 0 | $ 0 | $ 0 |
Loans - Schedule of Activity in
Loans - Schedule of Activity in Allowance for Loan Losses (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2019 | Sep. 30, 2018 | Sep. 30, 2019 | Sep. 30, 2018 | |
Financing Receivable Allowance For Credit Losses [Line Items] | ||||
Beginning balance | $ 9,525 | $ 9,723 | $ 9,636 | $ 9,139 |
Provision for loan losses | 290 | 439 | 691 | 1,047 |
Charge-offs | (175) | (622) | (688) | (650) |
Recoveries | 11 | 1 | 15 | |
Ending balance | 9,640 | 9,551 | 9,640 | 9,551 |
Commercial Real Estate | ||||
Financing Receivable Allowance For Credit Losses [Line Items] | ||||
Beginning balance | 5,554 | 4,804 | 4,805 | 4,801 |
Provision for loan losses | 102 | 271 | 851 | 274 |
Ending balance | 5,656 | 5,075 | 5,656 | 5,075 |
SBA Loans-Real Estate | ||||
Financing Receivable Allowance For Credit Losses [Line Items] | ||||
Beginning balance | 933 | 978 | 894 | 1,082 |
Provision for loan losses | 30 | 59 | (74) | |
Charge-offs | (20) | |||
Ending balance | 933 | 1,008 | 933 | 1,008 |
SBA Loans—Non-Real Estate | ||||
Financing Receivable Allowance For Credit Losses [Line Items] | ||||
Beginning balance | 119 | 536 | 505 | 538 |
Provision for loan losses | (2) | 89 | (388) | 112 |
Charge-offs | (57) | (85) | ||
Recoveries | 6 | 9 | ||
Ending balance | 117 | 574 | 117 | 574 |
Commercial and Industrial | ||||
Financing Receivable Allowance For Credit Losses [Line Items] | ||||
Beginning balance | 1,266 | 1,877 | 1,746 | 1,265 |
Provision for loan losses | 171 | 43 | 184 | 654 |
Charge-offs | (175) | (565) | (668) | (565) |
Recoveries | 5 | 6 | ||
Ending balance | 1,262 | 1,360 | 1,262 | 1,360 |
Home Mortgage | ||||
Financing Receivable Allowance For Credit Losses [Line Items] | ||||
Beginning balance | 1,609 | 1,489 | 1,653 | 1,408 |
Provision for loan losses | 26 | 12 | (18) | 93 |
Ending balance | 1,635 | 1,501 | 1,635 | 1,501 |
Consumer | ||||
Financing Receivable Allowance For Credit Losses [Line Items] | ||||
Beginning balance | 44 | 39 | 33 | 45 |
Provision for loan losses | (7) | (6) | 3 | (12) |
Recoveries | 1 | |||
Ending balance | $ 37 | $ 33 | $ 37 | $ 33 |
Loans - Schedule of Allowance f
Loans - Schedule of Allowance for Loan Losses and Recorded Investment in Loans by Portfolio Segment (Details) - USD ($) $ in Thousands | Sep. 30, 2019 | Jun. 30, 2019 | Dec. 31, 2018 | Sep. 30, 2018 | Jun. 30, 2018 | Dec. 31, 2017 |
Financing Receivable Allowance For Credit Losses [Line Items] | ||||||
Allowance for loan losses Individually Evaluated for Impairment | $ 336 | $ 1,198 | ||||
Allowance for Loan Collectively Evaluated for Impairment | 9,304 | 8,438 | ||||
Total | 9,640 | $ 9,525 | 9,636 | $ 9,551 | $ 9,723 | $ 9,139 |
Loans Individually Evaluated for Impairment | 860 | 2,407 | ||||
Loans Collectively Evaluated for Impairment | 966,385 | 875,436 | ||||
Total | 967,245 | 877,843 | ||||
Commercial Real Estate | ||||||
Financing Receivable Allowance For Credit Losses [Line Items] | ||||||
Allowance for Loan Collectively Evaluated for Impairment | 5,656 | 4,805 | ||||
Total | 5,656 | 5,554 | 4,805 | 5,075 | 4,804 | 4,801 |
Loans Collectively Evaluated for Impairment | 595,903 | 505,229 | ||||
Total | 595,903 | 505,229 | ||||
SBA Loans-Real Estate | ||||||
Financing Receivable Allowance For Credit Losses [Line Items] | ||||||
Allowance for Loan Collectively Evaluated for Impairment | 933 | 894 | ||||
Total | 933 | 933 | 894 | 1,008 | 978 | 1,082 |
Loans Individually Evaluated for Impairment | 488 | 834 | ||||
Loans Collectively Evaluated for Impairment | 125,085 | 117,159 | ||||
Total | 125,573 | 117,993 | ||||
SBA Loans—Non-Real Estate | ||||||
Financing Receivable Allowance For Credit Losses [Line Items] | ||||||
Allowance for loan losses Individually Evaluated for Impairment | 362 | |||||
Allowance for Loan Collectively Evaluated for Impairment | 117 | 143 | ||||
Total | 117 | 119 | 505 | 574 | 536 | 538 |
Loans Individually Evaluated for Impairment | 36 | 57 | ||||
Loans Collectively Evaluated for Impairment | 11,295 | 9,875 | ||||
Total | 11,331 | 9,932 | ||||
Commercial and Industrial | ||||||
Financing Receivable Allowance For Credit Losses [Line Items] | ||||||
Allowance for loan losses Individually Evaluated for Impairment | 336 | 836 | ||||
Allowance for Loan Collectively Evaluated for Impairment | 926 | 910 | ||||
Total | 1,262 | 1,266 | 1,746 | 1,360 | 1,877 | 1,265 |
Loans Individually Evaluated for Impairment | 336 | 1,516 | ||||
Loans Collectively Evaluated for Impairment | 107,646 | 112,781 | ||||
Total | 107,982 | 114,297 | ||||
Home Mortgage | ||||||
Financing Receivable Allowance For Credit Losses [Line Items] | ||||||
Allowance for Loan Collectively Evaluated for Impairment | 1,635 | 1,653 | ||||
Total | 1,635 | 1,609 | 1,653 | 1,501 | 1,489 | 1,408 |
Loans Collectively Evaluated for Impairment | 123,581 | 127,806 | ||||
Total | 123,581 | 127,806 | ||||
Consumer | ||||||
Financing Receivable Allowance For Credit Losses [Line Items] | ||||||
Allowance for Loan Collectively Evaluated for Impairment | 37 | 33 | ||||
Total | 37 | $ 44 | 33 | $ 33 | $ 39 | $ 45 |
Loans Collectively Evaluated for Impairment | 2,875 | 2,586 | ||||
Total | $ 2,875 | $ 2,586 |
Loans - Schedule of Information
Loans - Schedule of Information Related to Impaired Loans by Class of Loans (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2019 | Sep. 30, 2018 | Sep. 30, 2019 | Sep. 30, 2018 | |
Financing Receivable Impaired [Line Items] | ||||
Recorded investment | $ 860 | $ 1,661 | $ 860 | $ 1,661 |
Allowance Allocated | 336 | 779 | 336 | 779 |
Average Recorded Investment | 858 | 1,669 | 890 | 1,679 |
Interest Income Recognized | 5 | 16 | 15 | 47 |
SBA Loans—Real Estate | ||||
Financing Receivable Impaired [Line Items] | ||||
Recorded investment, With no related allowance recorded | 488 | 134 | 488 | 134 |
Average Recorded Investment, With no related allowance recorded | 493 | 138 | 505 | |
SBA Loans-Non-Real Estate | ||||
Financing Receivable Impaired [Line Items] | ||||
Recorded investment, With no related allowance recorded | 36 | 434 | 36 | 434 |
Allowance Allocated | 434 | 434 | ||
Average Recorded Investment, With no related allowance recorded | 28 | 46 | ||
Average Recorded Investment, With an allowance recorded | 434 | 443 | ||
Commercial And Industrial | ||||
Financing Receivable Impaired [Line Items] | ||||
Recorded investment, With no related allowance recorded | 748 | 748 | ||
Recorded investment, With an allowance recorded | 336 | 345 | 336 | 345 |
Allowance Allocated | 336 | 345 | 336 | 345 |
Average Recorded Investment, With no related allowance recorded | 749 | |||
Average Recorded Investment, With an allowance recorded | 337 | 348 | 339 | 350 |
Interest Income Recognized, With no related allowance recorded | 11 | |||
Interest Income Recognized, With an allowance recorded | $ 5 | 5 | $ 15 | 14 |
Home Mortgage | ||||
Financing Receivable Impaired [Line Items] | ||||
Recorded investment, With no related allowance recorded | 134 | 134 | ||
Average Recorded Investment, With no related allowance recorded | 137 | |||
Consumer | ||||
Financing Receivable Impaired [Line Items] | ||||
Recorded investment, With no related allowance recorded | $ 748 | 748 | ||
Average Recorded Investment, With no related allowance recorded | 749 | |||
Interest Income Recognized, With no related allowance recorded | $ 33 |
Loans - Schedule of Recorded In
Loans - Schedule of Recorded Investment in Nonaccrual Loans and Loans Past Due Greater Than 90 Days Still Accruing Interest by Class of Loans (Details) - USD ($) $ in Thousands | Sep. 30, 2019 | Dec. 31, 2018 |
Financing Receivable Recorded Investment Past Due [Line Items] | ||
Nonaccrual | $ 1,234 | $ 1,571 |
Total | 1,234 | 1,571 |
SBA Loans—Real Estate | ||
Financing Receivable Recorded Investment Past Due [Line Items] | ||
Nonaccrual | 488 | 834 |
Total | 488 | 834 |
SBA Loans-Non-Real Estate | ||
Financing Receivable Recorded Investment Past Due [Line Items] | ||
Nonaccrual | 36 | 57 |
Total | 36 | 57 |
Commercial And Industrial | ||
Financing Receivable Recorded Investment Past Due [Line Items] | ||
Nonaccrual | 710 | 680 |
Total | $ 710 | $ 680 |
Loans - Schedule of Aging of Re
Loans - Schedule of Aging of Recorded Investment in Past Due Loans (Details) - USD ($) $ in Thousands | Sep. 30, 2019 | Dec. 31, 2018 |
Financing Receivable Recorded Investment Past Due [Line Items] | ||
Past Due Loans | $ 3,869 | $ 1,440 |
Loans Not Past Due | 963,376 | 876,403 |
Total | 967,245 | 877,843 |
Commercial Real Estate | ||
Financing Receivable Recorded Investment Past Due [Line Items] | ||
Past Due Loans | 472 | |
Loans Not Past Due | 595,431 | 505,229 |
Total | 595,903 | 505,229 |
SBA Loans-Real Estate | ||
Financing Receivable Recorded Investment Past Due [Line Items] | ||
Past Due Loans | 1,873 | 311 |
Loans Not Past Due | 123,700 | 117,682 |
Total | 125,573 | 117,993 |
SBA Loans—Non-Real Estate | ||
Financing Receivable Recorded Investment Past Due [Line Items] | ||
Past Due Loans | 3 | |
Loans Not Past Due | 11,328 | 9,932 |
Total | 11,331 | 9,932 |
Commercial and Industrial | ||
Financing Receivable Recorded Investment Past Due [Line Items] | ||
Past Due Loans | 374 | 680 |
Loans Not Past Due | 107,608 | 113,617 |
Total | 107,982 | 114,297 |
Home Mortgage | ||
Financing Receivable Recorded Investment Past Due [Line Items] | ||
Past Due Loans | 1,147 | 449 |
Loans Not Past Due | 122,434 | 127,357 |
Total | 123,581 | 127,806 |
Consumer | ||
Financing Receivable Recorded Investment Past Due [Line Items] | ||
Loans Not Past Due | 2,875 | 2,586 |
Total | 2,875 | 2,586 |
30-59 Days Past Due | ||
Financing Receivable Recorded Investment Past Due [Line Items] | ||
Past Due Loans | 2,579 | 449 |
30-59 Days Past Due | Commercial Real Estate | ||
Financing Receivable Recorded Investment Past Due [Line Items] | ||
Past Due Loans | 472 | |
30-59 Days Past Due | SBA Loans-Real Estate | ||
Financing Receivable Recorded Investment Past Due [Line Items] | ||
Past Due Loans | 1,293 | |
30-59 Days Past Due | SBA Loans—Non-Real Estate | ||
Financing Receivable Recorded Investment Past Due [Line Items] | ||
Past Due Loans | 3 | |
30-59 Days Past Due | Commercial and Industrial | ||
Financing Receivable Recorded Investment Past Due [Line Items] | ||
Past Due Loans | 374 | |
30-59 Days Past Due | Home Mortgage | ||
Financing Receivable Recorded Investment Past Due [Line Items] | ||
Past Due Loans | 437 | 449 |
60-89 Days Past Due | ||
Financing Receivable Recorded Investment Past Due [Line Items] | ||
Past Due Loans | 580 | |
60-89 Days Past Due | SBA Loans-Real Estate | ||
Financing Receivable Recorded Investment Past Due [Line Items] | ||
Past Due Loans | 580 | |
> 90 Days Pass Due | ||
Financing Receivable Recorded Investment Past Due [Line Items] | ||
Past Due Loans | 710 | 991 |
> 90 Days Pass Due | SBA Loans-Real Estate | ||
Financing Receivable Recorded Investment Past Due [Line Items] | ||
Past Due Loans | 311 | |
> 90 Days Pass Due | Commercial and Industrial | ||
Financing Receivable Recorded Investment Past Due [Line Items] | ||
Past Due Loans | $ 680 | |
> 90 Days Pass Due | Home Mortgage | ||
Financing Receivable Recorded Investment Past Due [Line Items] | ||
Past Due Loans | $ 710 |
Loans - Schedule of Risk Catego
Loans - Schedule of Risk Category of Loans by Class of Loans (Details) - USD ($) $ in Thousands | Sep. 30, 2019 | Dec. 31, 2018 |
Financing Receivable Recorded Investment [Line Items] | ||
Total | $ 967,245 | $ 877,843 |
Commercial Real Estate | ||
Financing Receivable Recorded Investment [Line Items] | ||
Total | 595,903 | 505,229 |
SBA Loans-Real Estate | ||
Financing Receivable Recorded Investment [Line Items] | ||
Total | 125,573 | 117,993 |
SBA Loans—Non-Real Estate | ||
Financing Receivable Recorded Investment [Line Items] | ||
Total | 11,331 | 9,932 |
Commercial and Industrial | ||
Financing Receivable Recorded Investment [Line Items] | ||
Total | 107,982 | 114,297 |
Home Mortgage | ||
Financing Receivable Recorded Investment [Line Items] | ||
Total | 123,581 | 127,806 |
Consumer | ||
Financing Receivable Recorded Investment [Line Items] | ||
Total | 2,875 | 2,586 |
Pass | ||
Financing Receivable Recorded Investment [Line Items] | ||
Total | 962,316 | 874,254 |
Pass | Commercial Real Estate | ||
Financing Receivable Recorded Investment [Line Items] | ||
Total | 595,903 | 505,229 |
Pass | SBA Loans-Real Estate | ||
Financing Receivable Recorded Investment [Line Items] | ||
Total | 122,553 | 115,993 |
Pass | SBA Loans—Non-Real Estate | ||
Financing Receivable Recorded Investment [Line Items] | ||
Total | 11,281 | 9,859 |
Pass | Commercial and Industrial | ||
Financing Receivable Recorded Investment [Line Items] | ||
Total | 106,379 | 112,781 |
Pass | Home Mortgage | ||
Financing Receivable Recorded Investment [Line Items] | ||
Total | 123,325 | 127,806 |
Pass | Consumer | ||
Financing Receivable Recorded Investment [Line Items] | ||
Total | 2,875 | 2,586 |
Special Member | ||
Financing Receivable Recorded Investment [Line Items] | ||
Total | 1,680 | 16 |
Special Member | SBA Loans-Real Estate | ||
Financing Receivable Recorded Investment [Line Items] | ||
Total | 773 | |
Special Member | SBA Loans—Non-Real Estate | ||
Financing Receivable Recorded Investment [Line Items] | ||
Total | 14 | 16 |
Special Member | Commercial and Industrial | ||
Financing Receivable Recorded Investment [Line Items] | ||
Total | 893 | |
Substandard | ||
Financing Receivable Recorded Investment [Line Items] | ||
Total | 3,249 | 3,573 |
Substandard | SBA Loans-Real Estate | ||
Financing Receivable Recorded Investment [Line Items] | ||
Total | 2,247 | 2,000 |
Substandard | SBA Loans—Non-Real Estate | ||
Financing Receivable Recorded Investment [Line Items] | ||
Total | 36 | 57 |
Substandard | Commercial and Industrial | ||
Financing Receivable Recorded Investment [Line Items] | ||
Total | 710 | $ 1,516 |
Substandard | Home Mortgage | ||
Financing Receivable Recorded Investment [Line Items] | ||
Total | $ 256 |
Leases - Additional Information
Leases - Additional Information (Details) - USD ($) | 3 Months Ended | 9 Months Ended | ||||
Sep. 30, 2019 | Sep. 30, 2018 | Sep. 30, 2019 | Sep. 30, 2018 | Jan. 01, 2019 | ||
Lessee Lease Description [Line Items] | ||||||
Remaining operating lease terms | 6 years | 6 years | ||||
Operating lease liabilities | [1] | $ 10,335,000 | $ 10,335,000 | |||
Operating right-of-use assets | [1] | 8,606,000 | 8,606,000 | |||
Operating lease rent expense | $ 655,000 | $ 545,000 | $ 1,800,000 | $ 1,600,000 | ||
ASU 2016-02 | ||||||
Lessee Lease Description [Line Items] | ||||||
Lease renewal term | 5 years | 5 years | ||||
Operating lease, existence of option to terminate [true false] | true | |||||
Operating lease, Option to terminate description | Certain lease arrangements contain extension option which are typically around 5 years. | |||||
Operating lease liabilities | $ 9,900,000 | |||||
Operating right-of-use assets | $ 8,606,000 | $ 8,606,000 | $ 8,000,000 | |||
ASU 2016-02 | Minimum | ||||||
Lessee Lease Description [Line Items] | ||||||
Remaining operating lease terms | 1 year | 1 year | ||||
ASU 2016-02 | Maximum | ||||||
Lessee Lease Description [Line Items] | ||||||
Remaining operating lease terms | 10 years | 10 years | ||||
[1] | The adoption of ASU 2016-02, Leases (Topic 842) in the first quarter of 2019 resulted in the recognition of right-of-use assets and lease liabilities on balance sheet. |
Leases - Summary of Lease Cost
Leases - Summary of Lease Cost (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended |
Sep. 30, 2019 | Sep. 30, 2019 | |
Leases [Abstract] | ||
Operating lease cost | $ 444 | $ 1,287 |
Variable lease cost | 211 | 548 |
Total lease cost | $ 655 | $ 1,835 |
Leases - Summary of Other Infor
Leases - Summary of Other Information Related to Operating Leases (Details) $ in Thousands | 3 Months Ended | 9 Months Ended |
Sep. 30, 2019USD ($) | Sep. 30, 2019USD ($) | |
Cash paid for amounts included in the measurement of lease liabilities: | ||
Operating cash flows from operating leases | $ 493 | $ 1,408 |
Weighted average remaining lease term - operating leases | 6 years | 6 years |
Weighted average discount rate - operating leases | 2.98% | 2.98% |
Leases - Summary of Remaining C
Leases - Summary of Remaining Contractually Obligated Lease Payments and Reconciliation to Lease liability (Details) $ in Thousands | Sep. 30, 2019USD ($) | |
Leases [Abstract] | ||
2019 remaining | $ 301 | |
2020 | 2,002 | |
2021 | 2,032 | |
2022 | 2,028 | |
2023 | 1,816 | |
Thereafter | 3,343 | |
Total lease payments | 11,522 | |
Discount to present value | (1,187) | |
Total lease liability | $ 10,335 | [1] |
[1] | The adoption of ASU 2016-02, Leases (Topic 842) in the first quarter of 2019 resulted in the recognition of right-of-use assets and lease liabilities on balance sheet. |
Leases - Summary of Rent Commit
Leases - Summary of Rent Commitments Related to Lease (Details) $ in Thousands | Dec. 31, 2018USD ($) |
Leases [Abstract] | |
2019 | $ 1,709 |
2020 | 1,757 |
2021 | 1,742 |
2022 | 1,685 |
2023 | 1,455 |
Thereafter | 2,669 |
Total | $ 11,017 |
Premises and Equipment - Schedu
Premises and Equipment - Schedule of Premises and Equipment (Details) - USD ($) $ in Thousands | Sep. 30, 2019 | Dec. 31, 2018 |
Property Plant And Equipment [Line Items] | ||
Total cost | $ 11,989 | $ 10,420 |
Accumulated depreciation | (6,622) | (5,787) |
Net book value | 5,367 | 4,633 |
Leasehold Improvements | ||
Property Plant And Equipment [Line Items] | ||
Total cost | 6,505 | 5,518 |
Furniture and Fixtures | ||
Property Plant And Equipment [Line Items] | ||
Total cost | 3,155 | 2,791 |
Equipment and Others | ||
Property Plant And Equipment [Line Items] | ||
Total cost | $ 2,329 | $ 2,111 |
Premises and Equipment - Additi
Premises and Equipment - Additional Information (Details) - USD ($) | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2019 | Sep. 30, 2018 | Sep. 30, 2019 | Sep. 30, 2018 | |
Property Plant And Equipment [Abstract] | ||||
Depreciation expense | $ 297,000 | $ 273,000 | $ 835,000 | $ 762,000 |
Servicing Assets - Schedule of
Servicing Assets - Schedule of Activity for Loan Servicing Assets (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2019 | Sep. 30, 2018 | Sep. 30, 2019 | Sep. 30, 2018 | |
Servicing Asset [Abstract] | ||||
Beginning balance | $ 6,996 | $ 6,994 | $ 6,987 | $ 6,771 |
Additions | 552 | 588 | 1,553 | 1,621 |
Amortized to expense | (589) | (485) | (1,581) | (1,295) |
Ending balance | $ 6,959 | $ 7,097 | $ 6,959 | $ 7,097 |
Servicing Assets - Additional I
Servicing Assets - Additional Information (Details) - USD ($) | 9 Months Ended | |
Sep. 30, 2019 | Sep. 30, 2018 | |
Servicing Assets At Amortized Value [Line Items] | ||
Valuation allowance against carrying value of servicing assets | $ 0 | $ 0 |
Servicing asset at fair value, amount | $ 8,300,000 | $ 8,600,000 |
Minimum | ||
Servicing Assets At Amortized Value [Line Items] | ||
Fair value of servicing assets, discount rates | 1.80% | 4.70% |
Fair value of servicing assets, prepayment speed | 13.40% | 11.40% |
Maximum | ||
Servicing Assets At Amortized Value [Line Items] | ||
Fair value of servicing assets, discount rates | 10.00% | 11.00% |
Fair value of servicing assets, prepayment speed | 14.60% | 13.30% |
Deposits - Schedule of Maturiti
Deposits - Schedule of Maturities of Time Deposits (Details) $ in Thousands | Sep. 30, 2019USD ($) |
Deposits [Abstract] | |
2019 remaining | $ 124,973 |
2020 | 288,900 |
2021 | 5,458 |
2022 | 972 |
2023 | 724 |
Thereafter | 121 |
Total | $ 421,148 |
Deposits - Additional Informati
Deposits - Additional Information (Details) - USD ($) | Sep. 30, 2019 | Dec. 31, 2018 |
Principal Officers, Directors, and Affiliates | ||
Time Deposits [Line Items] | ||
Deposits from principal officers, directors, and their affiliates | $ 1,100,000 | $ 778,000 |
Borrowing Arrangements - Additi
Borrowing Arrangements - Additional Information (Details) | Sep. 30, 2019USD ($) |
Debt Disclosure [Abstract] | |
Federal home loan bank borrowings | $ 0 |
Letter of credit | 49,000,000 |
Collateral pledged | $ 811,500,000 |
Borrowing Arrangements - Summar
Borrowing Arrangements - Summary of Borrowings Available to the Company from Institutions (Details) $ in Thousands | Sep. 30, 2019USD ($) |
Debt Disclosure [Line Items] | |
Amount of borrowings | $ 366,654 |
Federal Home Loan Bank—San Francisco | |
Debt Disclosure [Line Items] | |
Amount of borrowings | 232,865 |
Federal Reserve Bank | |
Debt Disclosure [Line Items] | |
Amount of borrowings | 120,289 |
Pacific Coast Bankers Bank | |
Debt Disclosure [Line Items] | |
Amount of borrowings | 8,000 |
Zions Bank | |
Debt Disclosure [Line Items] | |
Amount of borrowings | $ 5,500 |
Income Taxes - Additional Infor
Income Taxes - Additional Information (Details) - USD ($) | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2019 | Sep. 30, 2018 | Sep. 30, 2019 | Sep. 30, 2018 | |
Income Tax Disclosure [Abstract] | ||||
Income tax expense | $ 1,237,000 | $ 1,144,000 | $ 3,984,000 | $ 3,781,000 |
Effective income tax rate | 23.60% | 24.70% | 24.10% | 26.50% |
Unrealized tax benefits | $ 0 | $ 0 | $ 0 | $ 0 |
Commitments and Contingencies -
Commitments and Contingencies - Summary of Distribution of Undisbursed Loan Commitments (Details) - USD ($) $ in Thousands | Sep. 30, 2019 | Dec. 31, 2018 |
Fair Value Off Balance Sheet Risks Disclosure Information [Line Items] | ||
Undisbursed loan commitments | $ 81,050 | $ 63,788 |
Commitments to Extend Credit | ||
Fair Value Off Balance Sheet Risks Disclosure Information [Line Items] | ||
Undisbursed loan commitments | 76,094 | 60,789 |
Standby Letter of Credit | ||
Fair Value Off Balance Sheet Risks Disclosure Information [Line Items] | ||
Undisbursed loan commitments | 3,983 | 1,790 |
Commercial Letter of Credit | ||
Fair Value Off Balance Sheet Risks Disclosure Information [Line Items] | ||
Undisbursed loan commitments | $ 973 | $ 1,209 |
Stock-based Compensation - Addi
Stock-based Compensation - Additional Information (Details) - USD ($) | 3 Months Ended | 9 Months Ended | ||||
Sep. 30, 2019 | Sep. 30, 2018 | Sep. 30, 2019 | Sep. 30, 2018 | Dec. 31, 2013 | Dec. 31, 2012 | |
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||||
Share based compensation expense | $ 189,000 | $ 167,000 | $ 905,000 | $ 606,000 | ||
2005 Plan | ||||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||||
Share-based compensation shares authorized under stock option plans | 770,000 | 770,000 | ||||
Percent of the fair value options granted | 100.00% | |||||
Shares available for grant | 0 | 0 | ||||
Weighted average remaining contractual term stock options outstanding | 2 years 9 months 7 days | |||||
Weighted average remaining contractual life for options exercisable | 2 years 9 months 7 days | |||||
2005 Plan | Employee Stock Option | ||||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||||
Vesting period | 5 years | |||||
Stock options, when granted, expiration period | 10 years | |||||
2010 Plan | ||||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||||
Share-based compensation shares authorized under stock option plans | 95,427 | 95,427 | 2,500,000 | 1,350,000 | ||
Percent of the fair value options granted | 100.00% | |||||
Weighted average remaining contractual term stock options outstanding | 2 years 7 months 2 days | |||||
Weighted average remaining contractual life for options exercisable | 2 years 3 months 18 days | |||||
Number of options outstanding, Granted | 0 | 0 | ||||
Unrecognized compensation costs related to unvested stock options | $ 1,900,000 | $ 1,900,000 | ||||
Unrecognized compensation costs weighted average period | 1 year 2 months 12 days | |||||
2010 Plan | Employee Stock Option | ||||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||||
Vesting period | 5 years | |||||
Stock options, when granted, expiration period | 10 years | |||||
2010 Plan | Restricted Stock Awards | ||||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||||
Vesting period | 3 years | 3 years | ||||
Restricted stock awards granted | 3,000 | 148,000 | ||||
Weighted average fair value of Restricted shares granted | $ 8.15 | $ 12.7 |
Stock-based Compensation - Summ
Stock-based Compensation - Summary of Stock-based Compensation Stock Options Activity (Details) - USD ($) $ / shares in Units, $ in Thousands | 9 Months Ended | |
Sep. 30, 2019 | Sep. 30, 2018 | |
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||
Number of options outstanding, Beginning of period | 250,000 | |
Number of options outstanding, Exercised | (95,000) | |
Number of options outstanding, Ending of year | 155,000 | |
Number of options outstanding, Full vested and expected to vest | 155,000 | |
Number of options outstanding, Vested | 155,000 | |
2005 Plan | ||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||
Weighted average exercise price, Outstanding beginning | $ 4 | |
Weighted average exercise price, Exercised | 2.20 | |
Weighted average exercise price, Outstanding ending | 4.70 | |
Weighted average exercise price, Full vested and expected to vest | 4.70 | |
Weighted average exercise price, Vested | $ 4.70 | |
Aggregate intrinsic value, Outstanding | $ 787 | |
Aggregate intrinsic value, Fully vested and expected to vest | 787 | |
Aggregate intrinsic value, Vested | $ 787 | |
2010 Plan | ||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||
Number of options outstanding, Beginning of period | 620,000 | |
Number of options outstanding, Granted | 0 | 0 |
Number of options outstanding, Exercised | (165,000) | |
Number of options outstanding, Ending of year | 455,000 | |
Number of options outstanding, Full vested and expected to vest | 440,000 | |
Number of options outstanding, Vested | 395,000 | |
Weighted average exercise price, Outstanding beginning | $ 4.57 | |
Weighted average exercise price, Exercised | 1.12 | |
Weighted average exercise price, Outstanding ending | 5.20 | |
Weighted average exercise price, Full vested and expected to vest | 5.10 | |
Weighted average exercise price, Vested | $ 4.77 | |
Aggregate intrinsic value, Outstanding | $ 2,085 | |
Aggregate intrinsic value, Fully vested and expected to vest | 2,058 | |
Aggregate intrinsic value, Vested | $ 1,978 |
Stock-based Compensation - Su_2
Stock-based Compensation - Summary of Information Related to Stock Option Plan (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2019 | Sep. 30, 2018 | Sep. 30, 2019 | Sep. 30, 2018 | |
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||
Cash received from option exercises | $ 364 | $ 514 | ||
2005 Plan | ||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||
Intrinsic value of options exercised | $ 206 | $ 234 | 593 | 487 |
Cash received from option exercises | 72 | 119 | 179 | 195 |
Tax benefit realized from option exercised | 5 | 5 | ||
2010 Plan | ||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||
Intrinsic value of options exercised | 1,090 | 876 | ||
Cash received from option exercises | 185 | 319 | ||
Tax benefit realized from option exercised | 285 | 160 | ||
2010 Plan | Restricted Stock Awards | ||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||
Tax benefit realized from awards vested | $ 141 | $ 272 | $ 144 | $ 285 |
Stock-based Compensation - Su_3
Stock-based Compensation - Summary of Changes in Non-vested Restricted Stock Awards (Details) - 2010 Plan - Restricted Stock Awards - USD ($) $ / shares in Units, $ in Thousands | 9 Months Ended | |
Sep. 30, 2019 | Sep. 30, 2018 | |
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||
Shares issued, Non-vested beginning of period | 436,000 | |
Shares issued, Awards granted | 3,000 | 148,000 |
Shares issued, Awards vested | (141,500) | |
Shares issued, Awards forfeited | (8,000) | |
Shares issued, Non-vested end of period | 289,500 | |
Weighted average grant date fair value, Non-vested beginning of period | $ 8.19 | |
Weighted average grant date fair value, Awards granted | 8.15 | |
Weighted average grant date fair value, Awards vested | 5.91 | |
Weighted average grant date fair value, Awards forfeited | 10.10 | |
Weighted average grant date fair value, Non-vested end of period | $ 9.25 | |
Aggregate intrinsic value, Non-vested end of year | $ 2,831 |
Employee Benefit Plan - Additio
Employee Benefit Plan - Additional Information (Details) - 401 (k) Plan - USD ($) | 9 Months Ended | |
Sep. 30, 2019 | Sep. 30, 2018 | |
Defined Contribution Plan Disclosure [Line Items] | ||
Eligibility age of employees for plan | 21 years | |
Employee minimum service period | 90 days | |
Employer contribution amount | $ 449,000 | $ 356,000 |
Revenue Recognition - Additiona
Revenue Recognition - Additional Information (Details) - USD ($) | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2019 | Sep. 30, 2018 | Sep. 30, 2019 | Sep. 30, 2018 | |
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items] | ||||
Service charges on deposits | $ 469,000 | $ 484,000 | $ 1,495,000 | $ 1,419,000 |
Noninterest income | $ 2,732,000 | $ 2,284,000 | 8,912,000 | 7,279,000 |
Service Fees and Transaction-Based Fees Income | ||||
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items] | ||||
Service charges on deposits | $ 545,000 | $ 558,000 | ||
Percentage on revenue | 1.30% | 1.50% | ||
Overdraft and NSF Fees Income | ||||
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items] | ||||
Service charges on deposits | $ 707,000 | $ 861,000 | ||
Percentage on revenue | 1.70% | 2.30% | ||
Wire Transfer Fee Income | ||||
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items] | ||||
Percentage on revenue | 0.60% | 0.70% | ||
Noninterest income | $ 243,000 | $ 243,000 |
Fair Value of Financial Instr_3
Fair Value of Financial Instruments - Summary of Assets and Liabilities Measured at Fair Value on Recurring Basis (Details) - USD ($) $ in Thousands | Sep. 30, 2019 | Dec. 31, 2018 |
Other investments: | ||
Mutual fund - CRA qualified | $ 3,625 | $ 2,488 |
Fair Value, Measurements, Recurring | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
U.S. Government sponsored agency securities | 5,992 | 6,906 |
Mortgage-backed securities - residential | 12,197 | 14,129 |
Collateralized mortgage obligations | 34,106 | 34,301 |
Other investments: | ||
Mutual fund - CRA qualified | 3,625 | 2,488 |
Fair Value, Measurements, Recurring | Quoted Prices in Active Markets (Level 1) | ||
Other investments: | ||
Mutual fund - CRA qualified | 3,625 | 2,488 |
Fair Value, Measurements, Recurring | Significant Other Observable Inputs (Level 2) | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
U.S. Government sponsored agency securities | 5,992 | 6,906 |
Mortgage-backed securities - residential | 12,197 | 14,129 |
Collateralized mortgage obligations | $ 34,106 | $ 34,301 |
Fair Value of Financial Instr_4
Fair Value of Financial Instruments - Additional Information (Details) - USD ($) | Sep. 30, 2019 | Dec. 31, 2018 | Sep. 30, 2018 |
Fair Value Disclosures [Abstract] | |||
Fair value assets transfers between level 1 to level 2 | $ 0 | $ 0 | |
Fair value liabilities transfers between level 1 to level 2 | 0 | $ 0 | |
Other assets measured at fair value | 0 | $ 0 | |
Liabilities measured at fair value | $ 0 | $ 0 |
Fair Value of Financial Instr_5
Fair Value of Financial Instruments - Carrying Amounts and Estimated Fair Values of Financial Instruments (Details) - USD ($) $ in Thousands | Sep. 30, 2019 | Dec. 31, 2018 |
Financial Assets: | ||
Cash and cash equivalents | $ 89,107 | $ 77,726 |
Loans held for sale | 397 | 806 |
Loans receivable, net | 980,317 | 862,394 |
Accrued interest receivable | 3,140 | 3,068 |
Financial Liabilities: | ||
Deposit | 997,256 | 904,466 |
Accrued interest payable | 2,541 | 1,715 |
Carrying Amount | ||
Financial Assets: | ||
Cash and cash equivalents | 89,107 | 77,726 |
Loans held for sale | 368 | 752 |
Loans receivable, net | 954,730 | 865,423 |
Accrued interest receivable | 3,140 | 3,068 |
Financial Liabilities: | ||
Deposit | 995,993 | 905,176 |
Accrued interest payable | 2,541 | 1,715 |
Level 1 | ||
Financial Assets: | ||
Cash and cash equivalents | 89,107 | 77,726 |
Accrued interest receivable | 19 | 44 |
Level 2 | ||
Financial Assets: | ||
Loans held for sale | 397 | 806 |
Accrued interest receivable | 246 | 240 |
Financial Liabilities: | ||
Deposit | 997,256 | 904,466 |
Accrued interest payable | 2,541 | 1,715 |
Level 3 | ||
Financial Assets: | ||
Loans receivable, net | 980,317 | 862,394 |
Accrued interest receivable | $ 2,875 | $ 2,784 |
Regulatory Capital Matters - Ad
Regulatory Capital Matters - Additional Information (Details) | 9 Months Ended | |
Sep. 30, 2019 | Dec. 31, 2016 | |
Regulatory Capital Requirements [Abstract] | ||
Capital conservation buffer | 2.50% | 0.625% |
Capital conservation buffer, percentage of annual increase until 2019 | 0.625% |
Regulatory Capital Matters - Su
Regulatory Capital Matters - Summary of Actual and Required Capital Amounts and Ratios, Exclusive of Capital Conservation Buffer (Details) - USD ($) $ in Thousands | Sep. 30, 2019 | Dec. 31, 2018 |
Consolidated | ||
Compliance With Regulatory Capital Requirements Under Banking Regulations [Line Items] | ||
Total capital (to risk-weighted assets), Actual Amount | $ 146,641 | $ 139,593 |
Tier 1 capital (to risk-weighted assets), Actual Amount | 136,922 | 129,893 |
Common equity Tier 1 capital (to risk-weighted assets), Actual Amount | 136,922 | 129,893 |
Tier 1 capital (to average assets), Actual Amount | $ 136,922 | $ 129,893 |
Total capital (to risk-weighted assets), Actual Ratio | 15.36% | 16.26% |
Tier 1 capital (to risk-weighted assets), Actual Ratio | 14.35% | 15.13% |
Common equity Tier 1 capital (to risk-weighted assets), Actual Ratio | 14.35% | 15.13% |
Tier 1 capital (to average assets), Actual Ratio | 12.11% | 12.88% |
Bank | ||
Compliance With Regulatory Capital Requirements Under Banking Regulations [Line Items] | ||
Total capital (to risk-weighted assets), Actual Amount | $ 143,407 | $ 139,538 |
Tier 1 capital (to risk-weighted assets), Actual Amount | 133,688 | 129,838 |
Common equity Tier 1 capital (to risk-weighted assets), Actual Amount | 133,688 | 129,838 |
Tier 1 capital (to average assets), Actual Amount | $ 133,688 | $ 129,838 |
Total capital (to risk-weighted assets), Actual Ratio | 15.03% | 16.25% |
Tier 1 capital (to risk-weighted assets), Actual Ratio | 14.01% | 15.12% |
Common equity Tier 1 capital (to risk-weighted assets), Actual Ratio | 14.01% | 15.12% |
Tier 1 capital (to average assets), Actual Ratio | 11.83% | 12.87% |
Total capital (to risk-weighted assets), Amount, Required for Capital Adequacy Purposes | $ 76,332 | $ 68,686 |
Tier 1 capital (to risk-weighted assets), Amount, Required for Capital Adequacy Purposes | 57,249 | 51,514 |
Common equity Tier 1 capital (to risk-weighted assets), Amount, Required for Capital Adequacy Purposes | 42,937 | 38,636 |
Tier 1 capital (to average assets), Amount, Required for Capital Adequacy Purposes | $ 45,212 | $ 40,346 |
Total capital (to risk-weighted assets), Ratio, Required for Capital Adequacy Purposes | 8.00% | 8.00% |
Tier 1 capital (to risk-weighted assets), Ratio, Required for Capital Adequacy Purposes | 6.00% | 6.00% |
Common equity Tier 1 capital (to risk-weighted assets), Ratio, Required for Capital Adequacy Purposes | 4.50% | 4.50% |
Tier 1 capital (to average assets), Ratio, Required for Capital Adequacy Purposes | 4.00% | 4.00% |
Total capital (to risk-weighted assets), Amount, Minimum To be Considered "Well Capitalized" | $ 95,415 | $ 85,857 |
Tier 1 capital (to risk-weighted assets), Amount, Minimum To be Considered "Well Capitalized" | 76,332 | 68,686 |
Common equity Tier 1 capital (to risk-weighted assets), Amount, Minimum To be Considered "Well Capitalized" | 62,020 | 55,807 |
Tier 1 capital (to average assets), Amount, Minimum To be Considered "Well Capitalized" | $ 56,515 | $ 50,432 |
Total capital (to risk-weighted assets), Ratio, Minimum To be Considered "Well Capitalized" | 10.00% | 10.00% |
Tier 1 capital (to risk-weighted assets), Ratio, Minimum To be Considered "Well Capitalized" | 8.00% | 8.00% |
Common equity Tier 1 capital (to risk-weighted assets), Ratio, Minimum To be Considered "Well Capitalized" | 6.50% | 6.50% |
Tier 1 capital (to average assets), Ratio, Minimum To be Considered "Well Capitalized" | 5.00% | 5.00% |
Earnings Per Share - Computatio
Earnings Per Share - Computation of Basic and Diluted Earnings Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands | 3 Months Ended | 9 Months Ended | ||||||
Sep. 30, 2019 | Jun. 30, 2019 | Mar. 31, 2019 | Sep. 30, 2018 | Jun. 30, 2018 | Mar. 31, 2018 | Sep. 30, 2019 | Sep. 30, 2018 | |
Basic | ||||||||
Net income | $ 4,000 | $ 3,836 | $ 4,740 | $ 3,481 | $ 3,791 | $ 3,216 | $ 12,576 | $ 10,489 |
Undistributed earnings allocated to participating securities | (81) | (107) | (309) | (320) | ||||
Net income allocated to common shares | $ 3,919 | $ 3,374 | $ 12,267 | $ 10,169 | ||||
Weighted average common shares outstanding | 15,768,654 | 15,714,226 | 15,756,886 | 14,870,232 | ||||
Basic earnings per common share | $ 0.25 | $ 0.22 | $ 0.78 | $ 0.68 | ||||
Diluted | ||||||||
Net income allocated to common shares | $ 3,918 | $ 3,375 | $ 12,267 | $ 10,169 | ||||
Weighted average common shares outstanding | 15,768,654 | 15,714,226 | 15,756,886 | 14,870,232 | ||||
Add: Dilutive effects of assumed exercises of stock options | 238,832 | 520,700 | 235,129 | 506,750 | ||||
Average shares and dilutive potential common shares | 16,007,486 | 16,234,926 | 15,992,015 | 15,376,982 | ||||
Diluted earnings per common share | $ 0.24 | $ 0.21 | $ 0.77 | $ 0.66 |
Earnings Per Share - Additional
Earnings Per Share - Additional Information (Details) - shares | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2019 | Sep. 30, 2018 | Sep. 30, 2019 | Sep. 30, 2018 | |
Earnings Per Share [Abstract] | ||||
Antidilutive shares of common stock excluded from computation of earnings per share | 0 | 0 | 0 | 0 |